| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Y-form DNA binding | 6.63e-06 | 4 | 238 | 3 | GO:0000403 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 8.54e-06 | 41 | 238 | 6 | GO:0000217 | |
| GeneOntologyMolecularFunction | glycine binding | 1.79e-05 | 14 | 238 | 4 | GO:0016594 | |
| GeneOntologyMolecularFunction | phosphatidate phosphatase activity | 1.79e-05 | 14 | 238 | 4 | GO:0008195 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated ion channel activity | 3.26e-05 | 6 | 238 | 3 | GO:0016933 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated chloride channel activity | 3.26e-05 | 6 | 238 | 3 | GO:0016934 | |
| GeneOntologyMolecularFunction | lipid phosphatase activity | 6.63e-05 | 19 | 238 | 4 | GO:0042577 | |
| GeneOntologyMolecularFunction | chloride channel activity | 7.56e-05 | 86 | 238 | 7 | GO:0005254 | |
| GeneOntologyMolecularFunction | inhibitory extracellular ligand-gated monoatomic ion channel activity | 8.96e-05 | 8 | 238 | 3 | GO:0005237 | |
| GeneOntologyMolecularFunction | kinase binding | ABL1 MYOM1 CDK12 PPP1R12B MAML1 PTPN22 LYST AXIN2 ACSL3 JTB CCNYL1 PER3 TBC1D14 MOB4 TTC28 RASGRF1 PARP8 APBA1 SPG11 PPEF2 OPA1 TFRC ELAVL1 EXOC2 NRG3 BORA | 9.82e-05 | 969 | 238 | 26 | GO:0019900 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | RAPGEF6 DOCK11 FRMD7 HERC1 VAV2 DOCK3 ARHGEF28 RASGRF1 MON1A ECT2 PREX2 | 1.08e-04 | 231 | 238 | 11 | GO:0005085 |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.29e-04 | 125 | 238 | 8 | GO:0015108 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 1.41e-04 | 2 | 238 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 1.41e-04 | 2 | 238 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 1.41e-04 | 2 | 238 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 1.41e-04 | 2 | 238 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | glycine-gated chloride ion channel activity | 1.41e-04 | 2 | 238 | 2 | GO:0022852 | |
| GeneOntologyMolecularFunction | DNA clamp unloader activity | 1.41e-04 | 2 | 238 | 2 | GO:0061860 | |
| GeneOntologyMolecularFunction | phosphatase activity | ENPP1 PLPPR3 PTPN22 PLPPR4 PTPRO PTPRQ TNS3 ALPI DUSP8 PPEF2 LPIN3 LPIN2 | 1.80e-04 | 287 | 238 | 12 | GO:0016791 |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 2.35e-04 | 103 | 238 | 7 | GO:0005253 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 2.57e-04 | 11 | 238 | 3 | GO:0005247 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 3.16e-04 | 50 | 238 | 5 | GO:0099095 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 4.23e-04 | 30 | 238 | 4 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 4.23e-04 | 30 | 238 | 4 | GO:0097472 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 4.66e-04 | 151 | 238 | 8 | GO:0008509 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | ABCA2 RAPGEF6 DOCK11 PPP1R12B FRMD7 SERPINF1 WRNIP1 ADGRV1 BIRC6 ELFN2 FZR1 SERPINB5 CCNYL1 TBC1D14 HERC1 VAV2 NSMAF TNS3 DOCK3 ARHGEF28 RASGRF1 PARP8 RALGAPB LMTK2 MON1A RFC1 ECT2 PREX2 NRG3 CDC20 SORL1 | 7.80e-04 | 1418 | 238 | 31 | GO:0030234 |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 8.36e-04 | 4 | 238 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 8.36e-04 | 4 | 238 | 2 | GO:0071614 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 1.00e-03 | 17 | 238 | 3 | GO:0008308 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.05e-03 | 171 | 238 | 8 | GO:0015103 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.06e-03 | 65 | 238 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.06e-03 | 65 | 238 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 1.38e-03 | 5 | 238 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 1.38e-03 | 5 | 238 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 1.38e-03 | 5 | 238 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 1.38e-03 | 5 | 238 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | four-way junction DNA binding | 1.41e-03 | 19 | 238 | 3 | GO:0000400 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.66e-03 | 143 | 238 | 7 | GO:0017124 | |
| GeneOntologyMolecularFunction | proline-rich region binding | 1.90e-03 | 21 | 238 | 3 | GO:0070064 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.27e-03 | 77 | 238 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | gated channel activity | GABRG3 TMC7 CLCNKA CLCNKB GLRA1 GLRA2 GRIN3B GLRA3 CACHD1 ANO6 CACNG4 | 2.32e-03 | 334 | 238 | 11 | GO:0022836 |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | ENPP1 PLPPR3 PTPN22 PLPPR4 PTPRO PTPRQ TNS3 ALPI DUSP8 PPEF2 LPIN3 LPIN2 | 2.40e-03 | 386 | 238 | 12 | GO:0042578 |
| GeneOntologyMolecularFunction | phosphatidic acid binding | 2.81e-03 | 24 | 238 | 3 | GO:0070300 | |
| GeneOntologyMolecularFunction | MutLalpha complex binding | 2.86e-03 | 7 | 238 | 2 | GO:0032405 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RAPGEF6 DOCK11 FRMD7 TBC1D14 HERC1 VAV2 TNS3 DOCK3 ARHGEF28 RASGRF1 RALGAPB MON1A ECT2 PREX2 | 3.19e-03 | 507 | 238 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RAPGEF6 DOCK11 FRMD7 TBC1D14 HERC1 VAV2 TNS3 DOCK3 ARHGEF28 RASGRF1 RALGAPB MON1A ECT2 PREX2 | 3.19e-03 | 507 | 238 | 14 | GO:0030695 |
| GeneOntologyBiologicalProcess | neuron projection development | SLC25A46 CDK16 SETX ABL1 MARK1 ENPP1 FRMD7 SERPINF1 NCAM2 ADGRV1 EZH2 FBXO38 CDKL5 NRXN3 PLPPR4 NRXN1 PTPRO MYPN BAIAP2 HERC1 CNTN1 HSPG2 ARHGEF28 RASGRF1 LMTK2 PUM2 SPG11 OPA1 KIF20B PREX2 CRP TENM3 TET1 CTNND2 CDC20 | 1.06e-06 | 1285 | 232 | 35 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | SLC25A46 CDK16 SETX ABL1 MARK1 ENPP1 FRMD7 SERPINF1 NCAM2 ADGRV1 EZH2 PRDM1 FBXO38 CDKL5 NRXN3 PLPPR4 NRXN1 PTPRO MYPN PTPRQ BAIAP2 HERC1 CNTN1 HSPG2 ARHGEF28 RASGRF1 LMTK2 PUM2 SPG11 OPA1 KIF20B PREX2 CRP TENM4 TENM3 TET1 CTNND2 CDC20 | 1.09e-06 | 1463 | 232 | 38 | GO:0048666 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | ABL1 ENPP1 CDKL5 NRXN3 PLPPR4 NRXN1 GLRA2 KMT2A BAIAP2 GRIN3B SHISA6 RASGRF1 PCLO DLGAP4 APBA1 GLRA3 SPG11 GRM2 USP8 CACNG4 CTNND2 NRG3 CDC20 | 1.85e-06 | 663 | 232 | 23 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | ABL1 ENPP1 CDKL5 NRXN3 PLPPR4 NRXN1 GLRA2 KMT2A BAIAP2 GRIN3B SHISA6 RASGRF1 PCLO DLGAP4 APBA1 GLRA3 SPG11 GRM2 USP8 CACNG4 CTNND2 NRG3 CDC20 | 1.90e-06 | 664 | 232 | 23 | GO:0099177 |
| GeneOntologyBiologicalProcess | synapse organization | SLC25A46 GABRG3 ABL1 MARK1 ELFN2 CDKL5 NRXN3 PLPPR4 NRXN1 PTPRO BAIAP2 SHISA6 SORBS2 PCLO DLGAP4 SPG11 OPA1 TENM4 TENM3 ELAVL2 CTNND2 NRG3 CDC20 | 3.19e-06 | 685 | 232 | 23 | GO:0050808 |
| GeneOntologyBiologicalProcess | synaptic signaling | GABRG3 ABL1 ENPP1 EZH2 CDKL5 NRXN3 STXBP3 PLPPR4 NRXN1 GLRA1 GLRA2 KMT2A BAIAP2 GRIN3B SHISA6 SORBS2 RASGRF1 PCLO DLGAP4 APBA1 GLRA3 SPG11 GRM2 USP8 CACNG4 CTNND2 NRG3 CDC20 | 5.42e-06 | 976 | 232 | 28 | GO:0099536 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GABRG3 ABL1 ENPP1 EZH2 CDKL5 NRXN3 STXBP3 PLPPR4 NRXN1 GLRA1 GLRA2 KMT2A BAIAP2 GRIN3B SHISA6 RASGRF1 PCLO DLGAP4 APBA1 GLRA3 SPG11 GRM2 USP8 CACNG4 CTNND2 NRG3 CDC20 | 6.64e-06 | 931 | 232 | 27 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GABRG3 ABL1 ENPP1 EZH2 CDKL5 NRXN3 STXBP3 PLPPR4 NRXN1 GLRA1 GLRA2 KMT2A BAIAP2 GRIN3B SHISA6 RASGRF1 PCLO DLGAP4 APBA1 GLRA3 SPG11 GRM2 USP8 CACNG4 CTNND2 NRG3 CDC20 | 6.64e-06 | 931 | 232 | 27 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GABRG3 ABL1 ENPP1 EZH2 CDKL5 NRXN3 STXBP3 PLPPR4 NRXN1 GLRA1 GLRA2 KMT2A BAIAP2 GRIN3B SHISA6 RASGRF1 PCLO DLGAP4 APBA1 GLRA3 SPG11 GRM2 USP8 CACNG4 CTNND2 NRG3 CDC20 | 7.75e-06 | 939 | 232 | 27 | GO:0099537 |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | SETX ABL1 SERPINF1 EZH2 FBXO38 NRXN1 BAIAP2 CNTN1 PUM2 OPA1 CRP TENM3 | 2.69e-05 | 249 | 232 | 12 | GO:0010976 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 3.95e-05 | 112 | 232 | 8 | GO:1902476 | |
| GeneOntologyBiologicalProcess | cell junction organization | SLC25A46 GABRG3 ABL1 MARK1 ELFN2 CDKL5 NRXN3 PLPPR4 NRXN1 PTPRO BAIAP2 SHISA6 SORBS2 PCLO DLGAP4 SPG11 ECT2 OPA1 TENM4 TENM3 ELAVL2 ILDR1 CTNND2 NRG3 CDC20 PHLDB2 | 4.11e-05 | 974 | 232 | 26 | GO:0034330 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | RAPGEF6 ABL1 DOCK11 IFT172 TTLL5 FRMD7 FSIP2 CDKL5 NRXN1 PTPRO FAM161A CFAP221 TBC1D14 VAV2 OFD1 RFX4 GALNT11 ANO6 CFAP74 SPAG17 | 7.49e-05 | 670 | 232 | 20 | GO:0120031 |
| GeneOntologyBiologicalProcess | positive regulation of dendrite development | 9.73e-05 | 22 | 232 | 4 | GO:1900006 | |
| GeneOntologyBiologicalProcess | cell projection assembly | RAPGEF6 ABL1 DOCK11 IFT172 TTLL5 FRMD7 FSIP2 CDKL5 NRXN1 PTPRO FAM161A CFAP221 TBC1D14 VAV2 OFD1 RFX4 GALNT11 ANO6 CFAP74 SPAG17 | 1.01e-04 | 685 | 232 | 20 | GO:0030031 |
| GeneOntologyBiologicalProcess | chloride transport | 1.02e-04 | 128 | 232 | 8 | GO:0006821 | |
| GeneOntologyBiologicalProcess | central nervous system myelin formation | 1.12e-04 | 9 | 232 | 3 | GO:0032289 | |
| GeneOntologyBiologicalProcess | DNA clamp unloading | 1.26e-04 | 2 | 232 | 2 | GO:0090618 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.40e-04 | 134 | 232 | 8 | GO:0098661 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 1.69e-04 | 175 | 232 | 9 | GO:0031644 | |
| GeneOntologyBiologicalProcess | cellular response to metal ion | SERPINF1 ADGRV1 NRXN1 GLRA1 GLRA2 GLRA3 ECT2 CRP TFRC SLC25A39 | 1.96e-04 | 219 | 232 | 10 | GO:0071248 |
| GeneOntologyBiologicalProcess | inorganic anion transport | 2.09e-04 | 180 | 232 | 9 | GO:0015698 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 2.09e-04 | 180 | 232 | 9 | GO:0060078 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 3.04e-04 | 150 | 232 | 8 | GO:0050773 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 3.47e-04 | 153 | 232 | 8 | GO:0098656 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylcholine metabolic process | 3.75e-04 | 3 | 232 | 2 | GO:0150173 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatidylcholine biosynthetic process | 3.75e-04 | 3 | 232 | 2 | GO:2001247 | |
| GeneOntologyBiologicalProcess | positive regulation of anaphase-promoting complex-dependent catabolic process | 3.75e-04 | 3 | 232 | 2 | GO:1905786 | |
| GeneOntologyBiologicalProcess | activation of blood coagulation via clotting cascade | 3.75e-04 | 3 | 232 | 2 | GO:0002543 | |
| GeneOntologyCellularComponent | chloride channel complex | 4.02e-06 | 57 | 241 | 7 | GO:0034707 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRG3 NCAM2 ELFN2 NRXN3 PLPPR4 NRXN1 PTPRO GLRA1 GLRA2 BAIAP2 GRIN3B SHISA6 CNTN1 APBA1 GLRA3 GRM2 TENM3 ANO6 CACNG4 | 5.00e-05 | 583 | 241 | 19 | GO:0097060 |
| GeneOntologyCellularComponent | microtubule organizing center | ABCA2 RAD18 RAPGEF6 IFT172 TTLL5 SFI1 BIRC6 AXIN2 ABRAXAS2 CDKL5 JTB FAM161A MTUS2 MCPH1 OFD1 TTC28 WRN ECT2 KIF20B LHCGR RESF1 CKAP2L RAB11FIP5 CDC20 PDZD2 | 6.48e-05 | 919 | 241 | 25 | GO:0005815 |
| GeneOntologyCellularComponent | somatodendritic compartment | GABRG3 ABL1 MARK1 ENPP1 FRMD7 SERPINF1 CDKL5 NRXN1 PTPRO GLRA1 BAIAP2 GRIN3B MOB4 SHISA6 SORBS2 RASGRF1 PCLO DLGAP4 CAPN2 APBA1 GLRA3 LMTK2 PUM2 SPG11 GRM2 OPA1 USP8 CACNG4 CTNND2 SORL1 | 8.43e-05 | 1228 | 241 | 30 | GO:0036477 |
| GeneOntologyCellularComponent | postsynapse | GABRG3 ABL1 ATR MARK1 ELFN2 CDKL5 PLPPR4 PTPRO GLRA1 GLRA2 BAIAP2 GRIN3B MOB4 SHISA6 CNTN1 PCLO DLGAP4 CAPN2 APBA1 GLRA3 GRM2 TFRC USP8 ELAVL1 CACNG4 CTNND2 | 1.28e-04 | 1018 | 241 | 26 | GO:0098794 |
| GeneOntologyCellularComponent | growth cone | SETX ABL1 FRMD7 CDKL5 NRXN1 PTPRO RASGRF1 PCLO LMTK2 KIF20B CRP | 1.36e-04 | 245 | 241 | 11 | GO:0030426 |
| GeneOntologyCellularComponent | dendrite | GABRG3 ABL1 MARK1 ENPP1 CDKL5 PTPRO GLRA1 BAIAP2 MOB4 SHISA6 SORBS2 RASGRF1 PCLO DLGAP4 CAPN2 APBA1 GLRA3 PUM2 SPG11 GRM2 OPA1 USP8 CTNND2 | 1.59e-04 | 858 | 241 | 23 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | GABRG3 ABL1 MARK1 ENPP1 CDKL5 PTPRO GLRA1 BAIAP2 MOB4 SHISA6 SORBS2 RASGRF1 PCLO DLGAP4 CAPN2 APBA1 GLRA3 PUM2 SPG11 GRM2 OPA1 USP8 CTNND2 | 1.65e-04 | 860 | 241 | 23 | GO:0097447 |
| GeneOntologyCellularComponent | site of polarized growth | SETX ABL1 FRMD7 CDKL5 NRXN1 PTPRO RASGRF1 PCLO LMTK2 KIF20B CRP | 1.80e-04 | 253 | 241 | 11 | GO:0030427 |
| GeneOntologyCellularComponent | glutamatergic synapse | MARK1 CDKL5 NRXN3 PLPPR4 NRXN1 PTPRO BAIAP2 MOB4 SHISA6 CNTN1 PCLO DLGAP4 APBA1 GRM2 USP8 TENM4 TENM3 ELAVL2 ELAVL1 CACNG4 CTNND2 NRG3 | 2.08e-04 | 817 | 241 | 22 | GO:0098978 |
| GeneOntologyCellularComponent | centrosome | RAD18 RAPGEF6 TTLL5 BIRC6 AXIN2 ABRAXAS2 CDKL5 JTB FAM161A MTUS2 MCPH1 OFD1 TTC28 WRN ECT2 KIF20B LHCGR CKAP2L RAB11FIP5 CDC20 PDZD2 | 2.46e-04 | 770 | 241 | 21 | GO:0005813 |
| GeneOntologyCellularComponent | Elg1 RFC-like complex | 3.94e-04 | 3 | 241 | 2 | GO:0031391 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 5.62e-04 | 201 | 241 | 9 | GO:0099634 | |
| GeneOntologyCellularComponent | postsynaptic specialization | ELFN2 CDKL5 PLPPR4 PTPRO GLRA1 GLRA2 BAIAP2 GRIN3B SHISA6 PCLO DLGAP4 GLRA3 USP8 CACNG4 CTNND2 | 7.82e-04 | 503 | 241 | 15 | GO:0099572 |
| GeneOntologyCellularComponent | midbody | 1.14e-03 | 222 | 241 | 9 | GO:0030496 | |
| GeneOntologyCellularComponent | glycinergic synapse | 1.49e-03 | 20 | 241 | 3 | GO:0098690 | |
| GeneOntologyCellularComponent | axon | SETX ABL1 FRMD7 SERPINF1 NCAM2 CDKL5 NRXN1 PTPRO GLRA1 MYPN CNTN1 RASGRF1 PCLO LMTK2 SPG11 GRM2 OPA1 KIF20B CRP TMEM230 TENM3 | 1.59e-03 | 891 | 241 | 21 | GO:0030424 |
| MousePheno | abnormal reflex | SLC25A46 ABCA2 SETX ENPP1 SLC26A4 FRMD7 WRNIP1 ADGRV1 LYST AXIN2 USP31 CDKL5 SERPINB5 FAM161A GLRA1 PTPRQ NUFIP2 HERC1 CLP1 NAXE DOCK3 SORBS2 MCPH1 PLEKHF2 PUM2 E2F3 SPG11 MON1A OPA1 PREX2 INTS10 ZNF106 SLC25A39 NCOA7 ELAVL1 ILDR1 SPAG17 PHLDB2 | 3.98e-06 | 1294 | 190 | 38 | MP:0001961 |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | SLC25A46 ABCA2 SETX ENPP1 SLC26A4 FRMD7 WRNIP1 ADGRV1 LYST AXIN2 USP31 CDKL5 SERPINB5 FAM161A GLRA1 PTPRQ NUFIP2 HERC1 CLP1 NAXE DOCK3 SORBS2 MCPH1 PLEKHF2 GLRA3 PUM2 E2F3 SPG11 MON1A OPA1 PREX2 INTS10 ZNF106 TENM3 SLC25A39 NCOA7 ELAVL1 ILDR1 SPAG17 PHLDB2 | 1.71e-05 | 1486 | 190 | 40 | MP:0002067 |
| Domain | ELAD_HUD_SF | 7.79e-06 | 4 | 235 | 3 | IPR006548 | |
| Domain | Glycine_rcpt_A | 7.79e-06 | 4 | 235 | 3 | IPR008127 | |
| Domain | EGF-like_CS | ITGB7 FAT1 NRXN3 NRXN1 C6 HSPG2 SNED1 MALRD1 TENM4 TENM3 NRG3 SORL1 | 1.22e-04 | 261 | 235 | 12 | IPR013032 |
| Domain | EGF_2 | ITGB7 FAT1 NRXN3 NRXN1 C6 HSPG2 SNED1 MALRD1 TENM4 TENM3 NRG3 SORL1 | 1.41e-04 | 265 | 235 | 12 | PS01186 |
| Domain | Cl_channel-K | 1.58e-04 | 2 | 235 | 2 | IPR002250 | |
| Domain | GABAA/Glycine_rcpt | 1.79e-04 | 23 | 235 | 4 | IPR006028 | |
| Domain | EGF_3 | FAT1 NRXN3 NRXN1 C6 HSPG2 SNED1 MALRD1 TENM4 TENM3 NRG3 SORL1 | 2.00e-04 | 235 | 235 | 11 | PS50026 |
| Domain | Hud_Sxl_RNA | 2.21e-04 | 10 | 235 | 3 | IPR002343 | |
| Domain | BRCT | 2.94e-04 | 26 | 235 | 4 | PS50172 | |
| Domain | EGF-like_dom | FAT1 NRXN3 NRXN1 C6 HSPG2 SNED1 MALRD1 TENM4 TENM3 NRG3 SORL1 | 3.29e-04 | 249 | 235 | 11 | IPR000742 |
| Domain | BRCT_dom | 3.95e-04 | 28 | 235 | 4 | IPR001357 | |
| Domain | EGF_1 | ITGB7 FAT1 NRXN3 NRXN1 C6 HSPG2 SNED1 MALRD1 TENM4 TENM3 NRG3 | 4.03e-04 | 255 | 235 | 11 | PS00022 |
| Domain | Rhs_assc_core | 4.69e-04 | 3 | 235 | 2 | IPR022385 | |
| Domain | Cdc20/Fizzy | 4.69e-04 | 3 | 235 | 2 | IPR033010 | |
| Domain | Lipin_N | 4.69e-04 | 3 | 235 | 2 | IPR007651 | |
| Domain | Lipin_mid | 4.69e-04 | 3 | 235 | 2 | IPR031703 | |
| Domain | Lipin_N | 4.69e-04 | 3 | 235 | 2 | PF04571 | |
| Domain | Lipin_mid | 4.69e-04 | 3 | 235 | 2 | PF16876 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK16 CDK18 RAPGEF6 SETX ABL1 AFTPH ERCC6L DOCK11 LYST CIC FSIP2 USP31 MAST4 KMT2A BAIAP2 TNS3 SORBS2 ARHGEF28 DRG2 OFD1 TTC28 PARP8 RALGAPB LMTK2 LARP1 ECT2 LPIN3 ZNF106 USP8 RESF1 TET1 RAB11FIP5 NCOA7 CDC20 PHLDB2 | 5.40e-17 | 861 | 243 | 35 | 36931259 |
| Pubmed | ERCC6L CDK12 SYTL2 WRNIP1 MAML1 BIRC6 GTF3C5 STXBP3 NUFIP2 GNL2 BAIAP2 MGA TNS3 DRG2 TTC28 CWC15 WDR70 LARP1 PUM2 RNF213 SPG11 TFRC TMEM230 ZNF106 USP8 TMEM131 CDC20 | 2.53e-12 | 733 | 243 | 27 | 34672954 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RAD18 RAPGEF6 AFTPH ATR ERCC6L CDK12 WRNIP1 POLA2 EZH2 CIC ACSL3 FBXO38 CCNYL1 RRP12 KMT2A ALPI SORBS2 RALGAPB ZNF507 LARP1 PUM2 RFC1 PPL ZNF106 EXOC2 COIL PHLDB2 | 8.79e-12 | 774 | 243 | 27 | 15302935 |
| Pubmed | CDK16 CDK18 RAPGEF6 DOCK11 MARK1 BIRC6 ABRAXAS2 ACSL3 BAIAP2 MOB4 SORBS2 OFD1 TTC28 PARP8 RALGAPB LARP1 USP8 THAP12 PHLDB2 | 4.70e-10 | 446 | 243 | 19 | 24255178 | |
| Pubmed | ABCA2 SETX CDK12 MAML1 SFI1 ADGRV1 TRANK1 NRXN3 MAST4 PLPPR4 ZNF608 ZNF507 LMTK2 LARP1 E2F3 SPG11 CACHD1 TET1 RAB11FIP5 | 7.67e-09 | 529 | 243 | 19 | 14621295 | |
| Pubmed | ATAD5 PPP1R12B PTPN22 BIRC6 CIC ABRAXAS2 ACSL3 USP31 FBXO38 STXBP3 RRP12 NUFIP2 GNL2 BAIAP2 HERC1 TNS3 OFD1 DUSP8 RALGAPB LMTK2 RNF213 CACHD1 PPEF2 OPA1 RAB11FIP5 COIL | 2.80e-08 | 1049 | 243 | 26 | 27880917 | |
| Pubmed | IFT172 URB2 SMC5 USP31 RRP12 NUFIP2 SORBS2 TTC28 DLGAP4 RALGAPB PUM2 OPA1 USP8 TENM4 TENM3 PDZD2 | 3.52e-08 | 407 | 243 | 16 | 12693553 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RAD18 SETX ATAD5 POLA2 EZH2 CIC GTF3C5 MEN1 FSIP2 FBXO38 GNL2 KMT2A MGA PHIP WDR70 WRN E2F3 RFC1 KIF20B | 6.92e-08 | 608 | 243 | 19 | 36089195 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 RAPGEF6 ABL1 CDK12 MAML1 SFI1 BIRC6 LYST CIC FZR1 FAT1 RRP12 HERC1 ZNF614 GAREM1 DOCK3 ENGASE HSPG2 OFD1 WDR70 LMTK2 LPIN3 SLC25A39 ANKRD34A HAS3 | 2.93e-07 | 1105 | 243 | 25 | 35748872 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | MYOM1 CDK12 PTPN22 FAT1 CLCNKA TP53RK TNS3 DOCK3 RASGRF1 WDR70 ECT2 ELAVL3 CTNND2 PHLDB2 | 3.02e-07 | 361 | 243 | 14 | 26167880 |
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 17920294 | ||
| Pubmed | 3.37e-07 | 3 | 243 | 3 | 26683461 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CDK16 RAD18 RAPGEF6 AFTPH ERCC6L WRNIP1 MAML1 POLA2 GTF3C5 ABRAXAS2 STXBP3 MYPN TBC1D14 TNS3 GAREM1 DRG2 COPB1 WDR70 MON1A LPIN3 RAB11FIP5 CDC20 COIL BORA | 3.49e-07 | 1038 | 243 | 24 | 26673895 |
| Pubmed | 3.62e-07 | 130 | 243 | 9 | 12421765 | ||
| Pubmed | 7.87e-07 | 105 | 243 | 8 | 9628581 | ||
| Pubmed | 1.34e-06 | 4 | 243 | 3 | 10848602 | ||
| Pubmed | Glycinergic input of widefield, displaced amacrine cells of the mouse retina. | 1.34e-06 | 4 | 243 | 3 | 19528249 | |
| Pubmed | 1.34e-06 | 4 | 243 | 3 | 21486797 | ||
| Pubmed | 1.34e-06 | 4 | 243 | 3 | 9051263 | ||
| Pubmed | 1.34e-06 | 4 | 243 | 3 | 21808035 | ||
| Pubmed | BRUCE regulates DNA double-strand break response by promoting USP8 deubiquitination of BRIT1. | 1.34e-06 | 4 | 243 | 3 | 25733871 | |
| Pubmed | 1.35e-06 | 152 | 243 | 9 | 38360978 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | DOCK11 IFT172 SERPINF1 WRNIP1 SMC5 NUFIP2 PHIP MTUS2 BTBD10 WDR70 PREX2 TENM4 ELAVL2 ELAVL1 ELAVL3 | 1.51e-06 | 475 | 243 | 15 | 31040226 |
| Pubmed | GABRG3 NCAM2 NRXN3 NRXN1 GLRA1 GLRA2 CNTN1 DLGAP4 GLRA3 GRM2 LHCGR NRG3 | 1.56e-06 | 300 | 243 | 12 | 19086053 | |
| Pubmed | RAPGEF6 BIRC6 CIC GTF3C5 ZNF608 CLP1 MGA DRG2 TTC28 ZNF507 KIF20B ZZZ3 RESF1 TET1 | 1.72e-06 | 418 | 243 | 14 | 34709266 | |
| Pubmed | MARK1 WRNIP1 PLPPR3 BIRC6 ELFN2 ACSL3 CDKL5 SERPINB5 PLPPR4 NRXN1 NUFIP2 BAIAP2 SHISA6 DOCK3 SORBS2 PCLO DLGAP4 CAPN2 APBA1 LMTK2 OPA1 TENM4 CTNND2 COIL | 1.78e-06 | 1139 | 243 | 24 | 36417873 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CENPB ATAD5 CDK12 URB2 SMC5 BIRC6 GTF3C5 RRP12 NUFIP2 GNL2 BTBD10 WRN LARP1 RFC1 ECT2 KIF20B CKAP2L ELAVL2 COIL | 1.95e-06 | 759 | 243 | 19 | 35915203 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CDK16 CDK18 CENPB IFT172 MAML1 GTF3C5 SRSF12 ACSL3 CCNYL1 NRXN1 PTPRQ NUFIP2 BAIAP2 MOB4 OFD1 WDR70 WRN LARP1 ECT2 OPA1 LPIN3 USP8 ANKRD34A EXOC2 PHLDB2 SORL1 | 2.25e-06 | 1321 | 243 | 26 | 27173435 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CDK16 RAD18 ERCC6L PPP1R12B SMC5 GTF3C5 FBXO38 FZR1 SERPINB5 PER3 RRP12 MYPN CLP1 MOB4 COPB1 CWC15 LARP1 ECT2 PPL TFRC ZNF106 CDC20 COIL BORA | 2.26e-06 | 1155 | 243 | 24 | 20360068 |
| Pubmed | 2.71e-06 | 87 | 243 | 7 | 12465718 | ||
| Pubmed | A genome-wide association study on obesity and obesity-related traits. | 2.99e-06 | 15 | 243 | 4 | 21552555 | |
| Pubmed | RAD18 SETX AFTPH CDK12 POLA2 EZH2 RRP12 MYPN NUFIP2 LARP1 RFC1 ECT2 TMEM131 COIL PHLDB2 | 3.04e-06 | 503 | 243 | 15 | 16964243 | |
| Pubmed | RAD18 ATAD5 MAML1 CIC PRDM1 FAT1 ZNF608 RRP12 GNL2 KMT2A HERC1 CLP1 MGA HSPG2 OFD1 COPB1 ZNF507 LARP1 PUM2 E2F3 RFC1 TFRC ZZZ3 RESF1 ELAVL2 ELAVL1 SORL1 | 3.04e-06 | 1429 | 243 | 27 | 35140242 | |
| Pubmed | MARK1 PPP1R12B WRNIP1 NCAM2 ELFN2 USP31 CDKL5 PLPPR4 NUFIP2 KMT2A BAIAP2 MTUS2 MOB4 CNTN1 SORBS2 VWF COPB1 PCLO DLGAP4 LARP1 GRM2 OPA1 TENM4 ELAVL1 ELAVL3 CTNND2 DNAH11 | 3.12e-06 | 1431 | 243 | 27 | 37142655 | |
| Pubmed | Developmental regulation of glycine receptors at efferent synapses of the murine cochlea. | 3.33e-06 | 5 | 243 | 3 | 21850450 | |
| Pubmed | Native glycine receptor subtypes and their physiological roles. | 3.33e-06 | 5 | 243 | 3 | 18721822 | |
| Pubmed | CDK12 ADGRV1 SMC5 BIRC6 NRXN1 ZNF608 TTC28 RALGAPB PUM2 TENM4 | 4.65e-06 | 225 | 243 | 10 | 12168954 | |
| Pubmed | A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. | 6.40e-06 | 65 | 243 | 6 | 27453043 | |
| Pubmed | A hierarchy of Hu RNA binding proteins in developing and adult neurons. | 6.63e-06 | 6 | 243 | 3 | 9096138 | |
| Pubmed | CDK16 RAPGEF6 MARK1 USP31 STXBP3 DLGAP4 RALGAPB CACHD1 OPA1 USP8 TENM3 RAB11FIP5 PHLDB2 | 9.66e-06 | 421 | 243 | 13 | 36976175 | |
| Pubmed | 1.08e-05 | 149 | 243 | 8 | 25184681 | ||
| Pubmed | 1.12e-05 | 197 | 243 | 9 | 36604605 | ||
| Pubmed | Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis. | 1.16e-05 | 7 | 243 | 3 | 36098964 | |
| Pubmed | Stabilization of Dll1 mRNA by Elavl1/HuR in neuroepithelial cells undergoing mitosis. | 1.16e-05 | 7 | 243 | 3 | 21346194 | |
| Pubmed | Glycine receptors support excitatory neurotransmitter release in developing mouse visual cortex. | 1.16e-05 | 7 | 243 | 3 | 22988142 | |
| Pubmed | SLC25A46 CDK18 MARK1 ADGRV1 SMC5 ELFN2 ACSL3 CDKL5 BAIAP2 SORBS2 DLGAP4 LARP1 ELAVL2 | 1.21e-05 | 430 | 243 | 13 | 32581705 | |
| Pubmed | 1.22e-05 | 199 | 243 | 9 | 23382691 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DOCK11 PTPN22 SMC5 TGM5 TRANK1 RRP12 GNL2 KMT2A HERC1 CWC15 SPG11 MON1A OPA1 ZNF106 | 1.23e-05 | 497 | 243 | 14 | 36774506 |
| Pubmed | ERCC6L ATAD5 MAML1 URB2 CIC GTF3C5 SERPINB5 TTC28 RFC1 CDY1 RAD51AP2 USP8 RAB11FIP5 ELAVL2 CTNND2 DNAH11 | 1.26e-05 | 638 | 243 | 16 | 31182584 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RAD18 SETX ATAD5 CDK12 SMC5 CIC SRSF12 NUFIP2 GNL2 KMT2A MGA PHIP CWC15 LARP1 RFC1 KIF20B ZZZ3 ELAVL1 ZNF830 COIL | 1.44e-05 | 954 | 243 | 20 | 36373674 |
| Pubmed | RAD18 SETX ATR ATAD5 WRNIP1 SMC5 GTF3C5 MGA MCPH1 WRN KIF20B ZNF106 ZZZ3 | 2.09e-05 | 453 | 243 | 13 | 29656893 | |
| Pubmed | 2.17e-05 | 164 | 243 | 8 | 32409323 | ||
| Pubmed | 2.29e-05 | 81 | 243 | 6 | 22723691 | ||
| Pubmed | CDK16 CDK18 RAPGEF6 MYOM1 ITGB7 PRDM1 NRXN1 ARHGEF28 XPNPEP2 | 2.50e-05 | 218 | 243 | 9 | 19460752 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RAPGEF6 AFTPH ERCC6L ATAD5 CDK12 CIC RRP12 NUFIP2 GNL2 KMT2A COPB1 CWC15 WDR70 LARP1 PUM2 RFC1 USP8 NCOA7 COIL | 3.56e-05 | 934 | 243 | 19 | 33916271 |
| Pubmed | 3.60e-05 | 27 | 243 | 4 | 19723784 | ||
| Pubmed | SETX MAML1 BIRC6 CDKL5 FAT1 BAIAP2 MGA TTC28 COPB1 WRN RNF213 PPL TENM3 ANO6 STK33 RAB11FIP5 COIL | 3.79e-05 | 777 | 243 | 17 | 35844135 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | CDK12 TTLL5 SYTL2 LYST CIC FAT1 TRANK1 PHIP VWF GLRA3 RNF213 XPNPEP2 CKAP2L DNAH11 | 3.90e-05 | 552 | 243 | 14 | 10737800 |
| Pubmed | Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias. | 4.86e-05 | 2 | 243 | 2 | 23100278 | |
| Pubmed | Characterization of the glycinergic input to bipolar cells of the mouse retina. | 4.86e-05 | 2 | 243 | 2 | 16420443 | |
| Pubmed | Association of CYP2C19 variants and epoxyeicosatrienoic acids on patients with microvascular angina. | 4.86e-05 | 2 | 243 | 2 | 27663770 | |
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 12124344 | ||
| Pubmed | Analyses of the interaction of WRNIP1 with Werner syndrome protein (WRN) in vitro and in the cell. | 4.86e-05 | 2 | 243 | 2 | 16769258 | |
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 4.86e-05 | 2 | 243 | 2 | 27335120 | |
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 37543682 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 10079173 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 25919862 | ||
| Pubmed | Important amino acid residues that confer CYP2C19 selective activity to CYP2C9. | 4.86e-05 | 2 | 243 | 2 | 18511451 | |
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 23834509 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 24105071 | ||
| Pubmed | Electrophysiological Signature of Homomeric and Heteromeric Glycine Receptor Channels. | 4.86e-05 | 2 | 243 | 2 | 27382060 | |
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 15385837 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 22391204 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 25518510 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 1909870 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 33477751 | ||
| Pubmed | Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development. | 4.86e-05 | 2 | 243 | 2 | 32587777 | |
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 32683556 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 15855721 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 14623888 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 23744037 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 22589111 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 23592782 | ||
| Pubmed | A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels. | 4.86e-05 | 2 | 243 | 2 | 20805576 | |
| Pubmed | CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population. | 4.86e-05 | 2 | 243 | 2 | 15660966 | |
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 23349306 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 33115391 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 17562299 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 10606752 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 36960518 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 26690534 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 17848572 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 19199010 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 19358898 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 27496708 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 34438105 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 30259282 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 17698910 | ||
| Pubmed | 4.86e-05 | 2 | 243 | 2 | 16198656 | ||
| Pubmed | [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration]. | 4.86e-05 | 2 | 243 | 2 | 15569425 | |
| Interaction | YWHAH interactions | CDK16 CDK18 ABCA2 RAPGEF6 SETX ABL1 AFTPH ERCC6L DOCK11 MARK1 NCAM2 POLA2 LYST CIC SRSF12 USP31 FZR1 MAST4 KMT2A BAIAP2 HERC1 TNS3 SORBS2 ARHGEF28 DRG2 OFD1 TTC28 PARP8 AGR2 RALGAPB LMTK2 LARP1 ECT2 LPIN3 ZNF106 USP8 RESF1 TET1 RAB11FIP5 NCOA7 ELAVL1 CDC20 PHLDB2 | 4.21e-12 | 1102 | 239 | 43 | int:YWHAH |
| Interaction | YWHAG interactions | CDK16 CDK18 RAPGEF6 ABL1 AFTPH ERCC6L DOCK11 MARK1 CDK12 NCAM2 EZH2 LYST CIC SRSF12 USP31 FZR1 MAST4 NUFIP2 KMT2A BAIAP2 TNS3 GAREM1 SORBS2 ARHGEF28 TTC28 COPB1 PARP8 AGR2 RALGAPB LMTK2 LARP1 PPEF2 LPIN3 ZNF106 USP8 TET1 ANKRD34A RAB11FIP5 ELAVL1 CDC20 PHLDB2 | 2.57e-09 | 1248 | 239 | 41 | int:YWHAG |
| Interaction | YWHAE interactions | CDK16 CDK18 RAD18 RAPGEF6 ABL1 DOCK11 MARK1 CDK12 NCAM2 SMC5 EZH2 LYST CIC USP31 FZR1 CCNYL1 MAST4 STXBP3 KMT2A BAIAP2 MGA GAREM1 SORBS2 ARHGEF28 TTC28 RASGRF1 PARP8 AGR2 CAPN2 RALGAPB LARP1 LPIN3 ZNF106 USP8 STK33 TET1 LPIN2 ANKRD34A RAB11FIP5 PHLDB2 | 9.93e-09 | 1256 | 239 | 40 | int:YWHAE |
| Interaction | YWHAB interactions | CDK16 CDK18 RAPGEF6 ABL1 DOCK11 MARK1 NCAM2 EZH2 LYST CIC SRSF12 USP31 MAST4 KMT2A BAIAP2 TNS3 SORBS2 ARHGEF28 TTC28 RASGRF1 PLEKHF2 PARP8 AGR2 RALGAPB LARP1 ECT2 LPIN3 ZNF106 USP8 ANKRD34A RAB11FIP5 ELAVL1 PHLDB2 | 1.40e-07 | 1014 | 239 | 33 | int:YWHAB |
| Interaction | YWHAZ interactions | CDK16 CDK18 RAPGEF6 ABL1 DOCK11 MARK1 NCAM2 SMC5 EZH2 LYST CIC FSIP2 USP31 FZR1 MAST4 NRXN1 PTPRO KMT2A BAIAP2 GAREM1 SORBS2 ARHGEF28 TTC28 COPB1 RASGRF1 PARP8 AGR2 RALGAPB LARP1 ECT2 LPIN3 USP8 LPIN2 ANKRD34A RAB11FIP5 EXOC2 PHLDB2 | 8.97e-07 | 1319 | 239 | 37 | int:YWHAZ |
| Interaction | RAB3IP interactions | CDK16 CDK18 ZC3H3 SRSF12 CCNYL1 BAIAP2 PPL USP8 ANKRD34A PHLDB2 | 1.14e-06 | 115 | 239 | 10 | int:RAB3IP |
| Interaction | YWHAQ interactions | CDK16 CDK18 RAPGEF6 ABL1 AFTPH DOCK11 MARK1 SMC5 EZH2 LYST CIC SRSF12 USP31 MAST4 NRXN1 KMT2A BAIAP2 TNS3 GAREM1 SORBS2 ARHGEF28 TTC28 PARP8 AGR2 LARP1 RFC1 GRM2 LPIN3 ZNF106 USP8 TET1 PHLDB2 | 3.54e-06 | 1118 | 239 | 32 | int:YWHAQ |
| Interaction | PDZD2 interactions | 5.02e-06 | 22 | 239 | 5 | int:PDZD2 | |
| Interaction | TERF2IP interactions | RAD18 SETX ATAD5 CDK12 WRNIP1 POLA2 EZH2 CIC GTF3C5 ZNF608 KMT2A MGA CWC15 WDR70 ZNF507 RFC1 ECT2 KIF20B ZZZ3 ZNF830 | 1.03e-05 | 552 | 239 | 20 | int:TERF2IP |
| Interaction | SH3PXD2A interactions | 2.24e-05 | 128 | 239 | 9 | int:SH3PXD2A | |
| Interaction | ZBTB21 interactions | CDK16 CIC SRSF12 FBXO38 BAIAP2 LARP1 LPIN3 ANKRD34A COIL PHLDB2 | 2.32e-05 | 161 | 239 | 10 | int:ZBTB21 |
| Interaction | DLG4 interactions | PLPPR3 ELFN2 CDKL5 FZR1 PLPPR4 NRXN1 BAIAP2 GRIN3B SHISA6 CNTN1 DOCK3 SORBS2 DLGAP4 APBA1 ELAVL1 CACNG4 PHLDB2 | 2.79e-05 | 449 | 239 | 17 | int:DLG4 |
| Interaction | KSR1 interactions | 2.86e-05 | 132 | 239 | 9 | int:KSR1 | |
| Interaction | PPP1CA interactions | RAD18 ATR PPP1R12B SYTL2 SFI1 CIC CDKL5 FZR1 MYPN CLP1 CNTN1 SORBS2 CWC15 AGR2 BTBD10 LMTK2 LARP1 ECT2 USP8 LPIN2 ELAVL1 SORL1 | 3.06e-05 | 696 | 239 | 22 | int:PPP1CA |
| Interaction | USP7 interactions | CDK16 RAD18 ABL1 CENPB ERCC6L WRNIP1 EZH2 CIC ABRAXAS2 FBXO38 CDKL5 FZR1 MYPN HERC1 PHIP DOCK3 OFD1 COPB1 AGR2 XPNPEP2 RFC1 ECT2 RFX4 OPA1 PREX2 PPL ZBBX LPIN3 SLC9A2 TENM4 LY75 COIL PHLDB2 | 3.57e-05 | 1313 | 239 | 33 | int:USP7 |
| Interaction | CTNND2 interactions | 4.19e-05 | 54 | 239 | 6 | int:CTNND2 | |
| Interaction | RPS6 interactions | RAD18 CDK12 MRPL27 URB2 EZH2 ZC3H3 CIC SRSF12 MEN1 FZR1 RRP12 GNL2 PHIP PCLO AGR2 WDR70 LARP1 RNF213 RFC1 GRM2 ECT2 ZNF106 ELAVL2 ELAVL1 COIL | 4.52e-05 | 874 | 239 | 25 | int:RPS6 |
| Interaction | AFDN interactions | CDK16 SMC5 SRSF12 MEN1 CDKL5 NRXN3 NRXN1 GNL2 KMT2A MTUS2 SORBS2 OFD1 ANKRD34A PHLDB2 | 4.71e-05 | 333 | 239 | 14 | int:AFDN |
| Interaction | ZNF638 interactions | CDK16 RAD18 SMC5 EZH2 SRSF12 MEN1 LARP1 LPIN3 RAD51AP2 ANKRD34A ELAVL1 PHLDB2 | 7.06e-05 | 261 | 239 | 12 | int:ZNF638 |
| Interaction | SFN interactions | RAPGEF6 ABL1 AFTPH ERCC6L DOCK11 MARK1 LYST USP31 SERPINB5 MAST4 KMT2A BAIAP2 TNS3 SORBS2 ARHGEF28 PLEKHF2 AGR2 LMTK2 LARP1 USP8 PHLDB2 | 8.30e-05 | 692 | 239 | 21 | int:SFN |
| Interaction | ZNF362 interactions | 1.05e-04 | 40 | 239 | 5 | int:ZNF362 | |
| Interaction | CHD8 interactions | 1.07e-04 | 193 | 239 | 10 | int:CHD8 | |
| Interaction | BUB3 interactions | RAD18 EZH2 CIC MEN1 FZR1 KMT2A PHIP AGR2 BTBD10 ELAVL1 CDC20 | 1.08e-04 | 232 | 239 | 11 | int:BUB3 |
| GeneFamily | Glycine receptors | 6.34e-06 | 5 | 157 | 3 | 868 | |
| GeneFamily | Cyclin dependent kinases | 7.05e-05 | 26 | 157 | 4 | 496 | |
| GeneFamily | Fibronectin type III domain containing | 7.91e-05 | 160 | 157 | 8 | 555 | |
| GeneFamily | Lipins | 2.24e-04 | 3 | 157 | 2 | 1043 | |
| GeneFamily | Phospholipid phosphatase related | 7.37e-04 | 5 | 157 | 2 | 1127 | |
| GeneFamily | WD repeat domain containing | 2.09e-03 | 262 | 157 | 8 | 362 | |
| GeneFamily | PDZ domain containing | 2.13e-03 | 152 | 157 | 6 | 1220 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.59e-03 | 9 | 157 | 2 | 1230 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.60e-03 | 66 | 157 | 4 | 722 | |
| GeneFamily | Chloride voltage-gated channels | 3.22e-03 | 10 | 157 | 2 | 302 | |
| Coexpression | PILON_KLF1_TARGETS_UP | RAD18 CYP2C19 CYP2C9 AFTPH TMC7 TTLL5 PER3 AFP KMT2A OGFRL1 VWF DUSP8 RALGAPB PUM2 CRP USP8 RESF1 LPIN2 | 2.72e-06 | 541 | 239 | 18 | MM1061 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | RAD18 RAPGEF6 SETX ATR SERPINF1 AP1AR STXBP3 GAREM1 WRN SPG11 RFC1 ECT2 OPA1 KIF20B USP8 ZZZ3 RESF1 CTNND2 SPESP1 SORL1 | 2.83e-06 | 656 | 239 | 20 | M18979 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | DOCK11 SYTL2 ADGRV1 LYST ACSL3 FBXO38 CDKL5 TNS3 GAREM1 OFD1 PLEKHF2 PARP8 PPL ANO6 NCOA7 CTNND2 PHLDB2 | 4.33e-06 | 504 | 239 | 17 | M2157 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RAPGEF6 MARK1 SYTL2 LYST TMEM132B SRSF12 FSIP2 NRXN3 MAST4 PLPPR4 NRXN1 PTPRO GLRA2 HERC1 MTUS2 VAV2 CNTN1 DOCK3 PCLO APBA1 ELAVL2 NCOA7 ELAVL3 CACNG4 CTNND2 SPAG17 | 1.04e-05 | 1106 | 239 | 26 | M39071 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 1.47e-05 | 157 | 239 | 9 | M7733 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | DOCK11 SMC5 NRXN1 ZNF608 TBC1D14 TNS3 PARP8 RFC1 LPIN2 SORL1 | 1.63e-05 | 200 | 239 | 10 | M8090 |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN | GABRG3 ABCA2 CYP2C19 MARK1 FAT1 TRANK1 ECT2 ZNF563 CKAP2L CACNG4 | 1.63e-05 | 200 | 239 | 10 | M7350 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RAPGEF6 SETX ATR DOCK11 PTPN22 SMC5 BIRC6 LYST ITGB7 PRDM1 TRANK1 NUFIP2 KMT2A HERC1 PHIP NSMAF WIPF1 OFD1 COPB1 PARP8 CAPN2 RALGAPB PUM2 RNF213 SPG11 RESF1 LPIN2 LSP1 ASB2 THAP12 SORL1 | 1.64e-05 | 1492 | 239 | 31 | M40023 |
| Coexpression | PILON_KLF1_TARGETS_UP | RAD18 AFTPH TMC7 TTLL5 PER3 AFP KMT2A OGFRL1 VWF DUSP8 RALGAPB PUM2 CRP USP8 RESF1 LPIN2 | 1.72e-05 | 503 | 239 | 16 | M2226 |
| Coexpression | GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN | 3.97e-05 | 178 | 239 | 9 | M2950 | |
| Coexpression | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN | 6.21e-05 | 24 | 239 | 4 | MM708 | |
| Coexpression | GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 9.39e-05 | 199 | 239 | 9 | M9498 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP | 9.39e-05 | 199 | 239 | 9 | M8103 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP | 9.39e-05 | 199 | 239 | 9 | M6412 | |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN | 9.39e-05 | 199 | 239 | 9 | M9031 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 9.39e-05 | 199 | 239 | 9 | M3070 | |
| Coexpression | GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP | 9.76e-05 | 200 | 239 | 9 | M9390 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN | 9.76e-05 | 200 | 239 | 9 | M9215 | |
| Coexpression | GSE12505_WT_VS_E2_2_HET_PDC_DN | 1.06e-04 | 158 | 239 | 8 | M439 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP | 1.20e-04 | 161 | 239 | 8 | M9446 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | RAD18 ERCC6L ATAD5 POLA2 EZH2 LYST ZNF608 GAREM1 OGFRL1 SORBS2 TTC28 PARP8 PCLO LARP1 E2F3 CACHD1 ECT2 KIF20B TFRC TENM4 TENM3 LPIN2 LSP1 LY75 PDZD2 | 9.01e-07 | 749 | 234 | 25 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | ABCA2 AFTPH NCAM2 ADGRV1 NRXN3 NRXN1 SORBS2 PCLO RFX4 ELAVL2 ELAVL3 NRG3 | 3.96e-06 | 210 | 234 | 12 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | RAD18 SETX AFTPH ATR ERCC6L SWT1 CDK12 PPP1R12B TTLL5 URB2 LYST AXIN2 PRDM1 ACSL3 USP31 TRANK1 HERC1 MGA DOCK3 OFD1 BTBD10 ECT2 TFRC TET1 ELAVL2 | 4.51e-06 | 820 | 234 | 25 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | RAD18 ERCC6L ATAD5 POLA2 EZH2 ZNF608 GAREM1 E2F3 ECT2 KIF20B TFRC TENM4 LY75 | 5.24e-05 | 316 | 234 | 13 | gudmap_kidney_P3_CapMes_Crym_k4_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NCAM2 SFI1 ADGRV1 FAT1 TRANK1 NRXN1 PTPRQ CNTN1 PCLO TENM4 SPAG17 DNAH11 | 4.51e-10 | 184 | 243 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NCAM2 SFI1 ADGRV1 FAT1 TRANK1 NRXN1 PTPRQ CNTN1 PCLO TENM4 SPAG17 DNAH11 | 4.51e-10 | 184 | 243 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NCAM2 SFI1 ADGRV1 FAT1 TRANK1 NRXN1 PTPRQ CNTN1 PCLO TENM4 SPAG17 DNAH11 | 4.51e-10 | 184 | 243 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | (07)_Ionocytes|World / shred by cell type by condition | DOCK11 PPP1R12B SERPINF1 MEN1 CLCNKA CLCNKB ATP6V1C2 GAREM1 VWF PLEKHF2 LPIN2 NCOA7 | 1.11e-09 | 199 | 243 | 12 | 8194777d367405a7840787e977854b5c07e3bd6b |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | CENPB IFT172 SYTL2 PLPPR3 CFAP221 PPL ZBBX STK33 CFAP74 SPAG17 DNAH11 | 9.43e-09 | 192 | 243 | 11 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-08 | 163 | 243 | 10 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-08 | 163 | 243 | 10 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NRXN1 CFAP221 C6 GRIN3B ZBBX STK33 ELAVL3 CFAP74 SPAG17 DNAH11 | 5.70e-08 | 179 | 243 | 10 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | GABRG3 TMEM132B NRXN3 PLPPR4 NRXN1 MTUS2 CNTN1 SORBS2 PCLO NRG3 | 1.33e-07 | 196 | 243 | 10 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DOCK11 FAT1 ZNF608 GLRA2 VAV2 PREX2 SLC9A2 TENM3 ELAVL2 CACNG4 | 1.33e-07 | 196 | 243 | 10 | 7af6c5147ac859353504d19727dbe24f63a29dd4 |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | ABCA2 SYTL2 TRAC PRDM1 TRANK1 KMT2A PARP8 RNF213 SPG11 RESF1 | 1.40e-07 | 197 | 243 | 10 | 836061acd7f0d5de89b16f52ec679bdf09eac9db |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | GABRG3 TMEM132B NRXN3 PLPPR4 NRXN1 MTUS2 CNTN1 SORBS2 PCLO NRG3 | 1.46e-07 | 198 | 243 | 10 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | GABRG3 TMEM132B NRXN3 PLPPR4 NRXN1 MTUS2 CNTN1 SORBS2 PCLO NRG3 | 1.46e-07 | 198 | 243 | 10 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | CFAP107 CFAP221 C6 GRIN3B AGR2 ZBBX STK33 CFAP74 SPAG17 DNAH11 | 1.53e-07 | 199 | 243 | 10 | b974b495cabbcc3934936cec846c0e2442a70ac3 |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | DOCK11 PRDM1 NRXN3 ZNF608 VAV2 SHISA6 SLC9A2 TENM3 ELAVL2 CACNG4 | 1.61e-07 | 200 | 243 | 10 | 347a510755374c6a66acee326565dfc447993f18 |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 3.78e-07 | 168 | 243 | 9 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | NCAM2 TMEM132B NRXN3 NRXN1 CNTN1 OGFRL1 CXorf66 FAM135B TENM3 | 3.78e-07 | 168 | 243 | 9 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-07 | 169 | 243 | 9 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-07 | 169 | 243 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.33e-07 | 175 | 243 | 9 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | FAM184B SLC26A4 FRMD7 NRXN3 CLCNKB TBC1D14 ATP6V1C2 VWA5B1 PDZD2 | 5.59e-07 | 176 | 243 | 9 | 25ebc8716aa44e44fce577701e3e82c6745a75ab |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.59e-07 | 176 | 243 | 9 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | NRXN3 CLCNKA CLCNKB TBC1D14 ATP6V1C2 VWA5B1 ARHGEF28 ELAVL2 NCOA7 | 5.59e-07 | 176 | 243 | 9 | 45028197364c64e93e3ffe86aff773d47a477d49 |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | SLC26A4 SERPINF1 SYTL2 NCAM2 ARHGEF28 SNED1 TENM3 ART3 PDZD2 | 7.07e-07 | 181 | 243 | 9 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | SLC26A4 CLCNKB ATP6V1C2 VWA5B1 GAREM1 ARHGEF28 NCOA7 PHLDB2 PDZD2 | 7.40e-07 | 182 | 243 | 9 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.40e-07 | 182 | 243 | 9 | f857b32de19240a8aca1685f7a78b4e53b04875c | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | FAM184B NRXN3 CLCNKA CLCNKB TBC1D14 ATP6V1C2 VWA5B1 ELAVL2 NCOA7 | 7.75e-07 | 183 | 243 | 9 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | ADGRV1 FAT1 MAST4 ZNF608 CFAP221 ATP6V1C2 GAREM1 CACHD1 MALRD1 | 8.49e-07 | 185 | 243 | 9 | 673f0c688ae6984bc8027df2da335787924f4137 |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.49e-07 | 185 | 243 | 9 | 30df02fbe2828e3c4f3e5c4cda855e74fb31be39 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.88e-07 | 186 | 243 | 9 | 96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.28e-07 | 187 | 243 | 9 | 8ff9f771d10c372d771c92dfa9006aa81aec4681 | |
| ToppCell | 21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | CFAP107 PLPPR3 CFAP221 GRIN3B ZBBX STK33 CFAP74 SPAG17 DNAH11 | 9.28e-07 | 187 | 243 | 9 | 1a2178a195d078d1963947b327c6d0d4f2f48341 |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 9.70e-07 | 188 | 243 | 9 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.11e-06 | 191 | 243 | 9 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.11e-06 | 191 | 243 | 9 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.11e-06 | 191 | 243 | 9 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | COVID-19-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class | 1.11e-06 | 191 | 243 | 9 | 4be3c6287965fe3a2f109d26f68bdc2fa393f99b | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | ADGRV1 MAST4 ZNF608 CFAP221 GAREM1 SORBS2 CACHD1 STK33 PDZD2 | 1.11e-06 | 191 | 243 | 9 | e432c6e1ae82dddf84314ce73d2b7a991630d905 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.11e-06 | 191 | 243 | 9 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class （2021.01.30） | 1.11e-06 | 191 | 243 | 9 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.11e-06 | 191 | 243 | 9 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.16e-06 | 192 | 243 | 9 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-06 | 193 | 243 | 9 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-06 | 193 | 243 | 9 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-06 | 193 | 243 | 9 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ADGRV1 ZNF608 FAM161A CFAP221 CACHD1 ZBBX CFAP74 SPAG17 DNAH11 | 1.21e-06 | 193 | 243 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-06 | 193 | 243 | 9 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-06 | 193 | 243 | 9 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-06 | 193 | 243 | 9 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-06 | 193 | 243 | 9 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-06 | 194 | 243 | 9 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-06 | 194 | 243 | 9 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-06 | 194 | 243 | 9 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | Mild-CD8+_T|World / Disease group and Cell class | 1.26e-06 | 194 | 243 | 9 | d64c2efb482bcdef9240977eae1023c4191286e7 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.31e-06 | 195 | 243 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 195 | 243 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 195 | 243 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_TRM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-06 | 196 | 243 | 9 | a65d6a2d9eb3fca8faf323dbc4430e53134b7221 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.37e-06 | 196 | 243 | 9 | 072e0e29be4639344ead4ea6ad521e3338f5f8af | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-06 | 197 | 243 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 146 | 243 | 8 | ec1f793409d1a81c0f9323eb3c82ffe01dae0e44 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.49e-06 | 198 | 243 | 9 | 16c54b884500066ade05a406915f9569ca8abdfc | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-06 | 198 | 243 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-06 | 198 | 243 | 9 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-06 | 199 | 243 | 9 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.55e-06 | 199 | 243 | 9 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-06 | 199 | 243 | 9 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-06 | 199 | 243 | 9 | 0486ab11f59f1ef52ddc42094f0f1e65f743a969 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-06 | 199 | 243 | 9 | f3e8bb9b58a7df3f074e0752af9e1213faef058b | |
| ToppCell | distal-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.55e-06 | 199 | 243 | 9 | 97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.62e-06 | 200 | 243 | 9 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 200 | 243 | 9 | cc906ff02fd335ff633b3b97afceb670494f910a | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_Tem|Control / Disease, condition lineage and cell class | 1.62e-06 | 200 | 243 | 9 | fddb3df5b90eb97ef8ed80fac320c1a90903f012 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.62e-06 | 200 | 243 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.62e-06 | 200 | 243 | 9 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.62e-06 | 200 | 243 | 9 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 200 | 243 | 9 | 873def69bf55ccbfc944bc10c5afc06be019c312 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-06 | 200 | 243 | 9 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-dn_T|IIF / Disease, condition lineage and cell class | 1.62e-06 | 200 | 243 | 9 | c34fff02992cba6bcc2308019cb00b94e1227300 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.62e-06 | 200 | 243 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 200 | 243 | 9 | 79e59ab31d3d3385b1b072dc75508af9546c2e1b | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.62e-06 | 200 | 243 | 9 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-06 | 200 | 243 | 9 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-06 | 200 | 243 | 9 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-06 | 200 | 243 | 9 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-06 | 200 | 243 | 9 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.62e-06 | 200 | 243 | 9 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Biopsy_Control_(H.)-Immune-T_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.62e-06 | 200 | 243 | 9 | 3545706d133b29df61affe8ac47b6c9fe85f7775 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.62e-06 | 200 | 243 | 9 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.62e-06 | 200 | 243 | 9 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.35e-06 | 156 | 243 | 8 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-06 | 157 | 243 | 8 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-06 | 160 | 243 | 8 | 14dfa519e68bab4bce890ddb66fa7763f18d9f19 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-06 | 160 | 243 | 8 | 839bbdfd4e4c7b48260c8bfb7670378634405e1d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-06 | 160 | 243 | 8 | 5b7789d4668ed7732babedc32d812233b430e0bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-06 | 160 | 243 | 8 | bba1486faaad5299e10f4fe17c6d149c28dc2560 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.57e-06 | 165 | 243 | 8 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 3.57e-06 | 165 | 243 | 8 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.90e-06 | 167 | 243 | 8 | edb722ee9b6ccd00fb038f702be8664020932659 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.08e-06 | 168 | 243 | 8 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| Drug | felbamate | 5.14e-08 | 70 | 240 | 9 | CID000003331 | |
| Drug | 7-ethoxycoumarin | 3.55e-06 | 86 | 240 | 8 | CID000035703 | |
| Drug | alpha-naphthoflavone | 4.56e-06 | 118 | 240 | 9 | CID000011790 | |
| Drug | protostrychnine | 4.59e-06 | 4 | 240 | 3 | CID005320746 | |
| Drug | 7-nitroindoline | 4.59e-06 | 4 | 240 | 3 | CID013566747 | |
| Drug | SC-49648 | 4.59e-06 | 4 | 240 | 3 | CID000195696 | |
| Drug | akuammiline | 4.59e-06 | 4 | 240 | 3 | CID005367018 | |
| Drug | N-methyl-THIP | 4.59e-06 | 4 | 240 | 3 | CID000134373 | |
| Drug | SC-48981 | 4.59e-06 | 4 | 240 | 3 | CID000126573 | |
| Drug | iso-THAZ | 4.59e-06 | 4 | 240 | 3 | CID003047783 | |
| Drug | 2-(phosphonomethyl)phenylalanine | 4.59e-06 | 4 | 240 | 3 | CID000383689 | |
| Drug | NSC381080 | 4.59e-06 | 4 | 240 | 3 | CID000165497 | |
| Drug | SC-50132 | 4.59e-06 | 4 | 240 | 3 | CID000195719 | |
| Drug | SR 42641 | 4.59e-06 | 4 | 240 | 3 | CID000129049 | |
| Drug | colchicoside | 5.58e-06 | 12 | 240 | 4 | CID000092763 | |
| Drug | ethoxyresorufin | 7.49e-06 | 95 | 240 | 8 | CID000003294 | |
| Drug | L-689,560 | 8.34e-06 | 27 | 240 | 5 | CID000121918 | |
| Drug | ifenprodil | 9.93e-06 | 71 | 240 | 7 | CID000003689 | |
| Drug | Lindane | 1.14e-05 | 5 | 240 | 3 | DB00431 | |
| Drug | pleiocarpamine | 1.14e-05 | 5 | 240 | 3 | CID000558637 | |
| Drug | azetidine-3-carboxylic acid | 1.14e-05 | 5 | 240 | 3 | CID000093192 | |
| Drug | Cao C | 1.14e-05 | 5 | 240 | 3 | CID000166617 | |
| Drug | oxanilide | 1.14e-05 | 5 | 240 | 3 | CID000069288 | |
| Drug | iso-THAO | 1.14e-05 | 5 | 240 | 3 | CID000127199 | |
| Drug | ALX1393 | 1.14e-05 | 5 | 240 | 3 | CID016078939 | |
| Drug | mono(2-ethyl-5-hydroxyhexyl) phthalate | 1.14e-05 | 5 | 240 | 3 | ctd:C479069 | |
| Drug | mafoprazine | 1.14e-05 | 5 | 240 | 3 | CID000071241 | |
| Drug | gevotroline | 1.14e-05 | 5 | 240 | 3 | CID000060546 | |
| Drug | AC1NUW3V | 1.21e-05 | 29 | 240 | 5 | CID005462126 | |
| Drug | ACEA-1011 | 1.50e-05 | 15 | 240 | 4 | CID000127872 | |
| Drug | milacemide | 1.50e-05 | 15 | 240 | 4 | CID000053568 | |
| Drug | NPC 12626 | 1.70e-05 | 31 | 240 | 5 | CID000108099 | |
| Drug | LY235959 | 1.70e-05 | 31 | 240 | 5 | CID000131938 | |
| Drug | eliprodil | 1.70e-05 | 31 | 240 | 5 | CID000060703 | |
| Drug | benzyloxyresorufin | 1.85e-05 | 78 | 240 | 7 | CID000114982 | |
| Drug | LY233536 | 1.98e-05 | 16 | 240 | 4 | CID000126239 | |
| Drug | indole-2-carboxylic acid | 1.99e-05 | 32 | 240 | 5 | CID000072899 | |
| Drug | DE gel | 2.17e-05 | 143 | 240 | 9 | CID000008146 | |
| Drug | THAZ | 2.26e-05 | 6 | 240 | 3 | CID000171289 | |
| Drug | mono(2-ethyl-5-oxohexyl)phthalate | 2.26e-05 | 6 | 240 | 3 | ctd:C080276 | |
| Drug | thiomuscimol | 2.26e-05 | 6 | 240 | 3 | CID000005448 | |
| Drug | thio-THIP | 2.26e-05 | 6 | 240 | 3 | CID000656720 | |
| Drug | AC1L90PQ | 2.26e-05 | 6 | 240 | 3 | CID000436036 | |
| Drug | mV GABA | 2.26e-05 | 6 | 240 | 3 | CID000128435 | |
| Drug | caged glycine | 2.26e-05 | 6 | 240 | 3 | CID000192642 | |
| Drug | brometone | 2.26e-05 | 6 | 240 | 3 | CID000006424 | |
| Drug | minaxolone | 2.26e-05 | 6 | 240 | 3 | CID000071960 | |
| Drug | hydroxyphenylacetic acid | 2.33e-05 | 33 | 240 | 5 | CID000011970 | |
| Drug | picrotoxin | GABRG3 SLC26A4 ADGRV1 CLCNKA CLCNKB GLRA1 GLRA2 GRIN3B GLRA3 GRM2 | 2.35e-05 | 181 | 240 | 10 | CID000031304 |
| Drug | 7-Cl-Thio-Kyna | 2.57e-05 | 17 | 240 | 4 | CID003035668 | |
| Drug | MNQX | 3.28e-05 | 18 | 240 | 4 | CID000130818 | |
| Drug | memantine | 3.51e-05 | 86 | 240 | 7 | CID000004054 | |
| Drug | C6H12NO5P | 3.60e-05 | 36 | 240 | 5 | CID000104962 | |
| Drug | 2-hydroxysaclofen | 3.64e-05 | 59 | 240 | 6 | CID000001564 | |
| Drug | miconazole | 3.64e-05 | 59 | 240 | 6 | CID000004189 | |
| Drug | 3-methylcholanthrene | CYP2C19 CYP2C9 IFT172 AFP UGT2B15 UGT2B17 PHIP DOCK3 COQ6 ELAVL3 HAS3 | 3.66e-05 | 231 | 240 | 11 | CID000001674 |
| Drug | IPSP | 3.78e-05 | 87 | 240 | 7 | CID000022083 | |
| Drug | L-serinamide | 3.92e-05 | 7 | 240 | 3 | CID000101138 | |
| Drug | Boc-glycine | 3.92e-05 | 7 | 240 | 3 | CID000078288 | |
| Drug | alpha-EMTBL | 3.92e-05 | 7 | 240 | 3 | CID000128423 | |
| Drug | CID189778 | 3.92e-05 | 7 | 240 | 3 | CID000189778 | |
| Drug | propyl methanethiosulfonate | 3.92e-05 | 7 | 240 | 3 | CID000529387 | |
| Drug | thiocolchicoside | 3.92e-05 | 7 | 240 | 3 | CID000072067 | |
| Drug | PK 8165 | 3.92e-05 | 7 | 240 | 3 | CID000071219 | |
| Drug | CGP 35348 | 4.84e-05 | 62 | 240 | 6 | CID000107699 | |
| Drug | propanethiol | 5.11e-05 | 20 | 240 | 4 | CID000007848 | |
| Drug | AP-7 | 5.30e-05 | 63 | 240 | 6 | CID000003122 | |
| Drug | HA-966 | 5.36e-05 | 39 | 240 | 5 | CID000001232 | |
| Drug | 4-aminobiphenyl | 5.42e-05 | 92 | 240 | 7 | CID000007102 | |
| Drug | niflumic acid | 5.53e-05 | 125 | 240 | 8 | CID000004488 | |
| Drug | hexobarbital | 6.19e-05 | 127 | 240 | 8 | CID000003608 | |
| Drug | WT702 | 6.23e-05 | 8 | 240 | 3 | CID000089643 | |
| Drug | isostrychnine | 6.23e-05 | 8 | 240 | 3 | CID000264626 | |
| Drug | R 5135 | 6.26e-05 | 21 | 240 | 4 | CID000119544 | |
| Drug | picrotoxinine | 6.33e-05 | 65 | 240 | 6 | CID000004816 | |
| Drug | NSC129536 | 9.27e-05 | 9 | 240 | 3 | CID000004815 | |
| Drug | Fluorescein | 9.27e-05 | 9 | 240 | 3 | ctd:D019793 | |
| Drug | Atonik | 9.27e-05 | 9 | 240 | 3 | CID000069471 | |
| Drug | nortropanol | 9.27e-05 | 9 | 240 | 3 | CID000068147 | |
| Drug | AC1NSJX8 | 9.27e-05 | 9 | 240 | 3 | CID005311059 | |
| Drug | SR 57227A | 9.27e-05 | 9 | 240 | 3 | CID000131746 | |
| Drug | DCQX | 9.27e-05 | 9 | 240 | 3 | CID000001845 | |
| Drug | phaclofen | 9.62e-05 | 70 | 240 | 6 | CID000001641 | |
| Drug | isoguvacine | 1.08e-04 | 45 | 240 | 5 | CID000003765 | |
| Drug | 7-chlorokynurenic acid | 1.08e-04 | 45 | 240 | 5 | CID000001884 | |
| Drug | SL 75102 | 1.08e-04 | 24 | 240 | 4 | CID005751746 | |
| Drug | dibenzylfluorescein | 1.11e-04 | 2 | 240 | 2 | ctd:C558664 | |
| Drug | rosiglitazone-metformin combination | 1.11e-04 | 2 | 240 | 2 | ctd:C471074 | |
| Drug | 4-nitrophenol | 1.14e-04 | 177 | 240 | 9 | CID000000980 | |
| Drug | sulconazole | 1.31e-04 | 10 | 240 | 3 | CID000005318 | |
| Drug | THBA | 1.31e-04 | 10 | 240 | 3 | CID000130993 | |
| Drug | aniline | 1.35e-04 | 142 | 240 | 8 | CID000006115 | |
| Drug | Cocaine | CDK18 RAPGEF6 CYP2C9 ABL1 MYOM1 ATAD5 MARK1 SLC26A4 ITGB7 AP1AR PER3 TBC1D14 HERC1 GRIN3B VWF RASGRF1 DUSP8 COQ6 EFCAB3 GRM2 CRP TFRC SLC9A2 TENM4 TENM3 EXOC2 CTNND2 COIL SORL1 | 1.38e-04 | 1314 | 240 | 29 | ctd:D003042 |
| Drug | 7-hydroxycoumarin | 1.41e-04 | 75 | 240 | 6 | CID005281426 | |
| Drug | V-X-A | 1.50e-04 | 26 | 240 | 4 | CID006369389 | |
| Drug | 2 E1 | 1.56e-04 | 145 | 240 | 8 | CID006102788 | |
| Drug | 5,7-dichlorokynurenic acid | 1.63e-04 | 49 | 240 | 5 | CID000001779 | |
| Drug | pitrazepin | 1.75e-04 | 27 | 240 | 4 | CID000146222 | |
| Drug | licochalcone A | 1.75e-04 | 27 | 240 | 4 | ctd:C070840 | |
| Drug | BP-7,8-diol | 1.76e-04 | 78 | 240 | 6 | CID000025892 | |
| Disease | Paroxysmal atrial fibrillation | 4.14e-05 | 156 | 238 | 8 | C0235480 | |
| Disease | familial atrial fibrillation | 4.14e-05 | 156 | 238 | 8 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.14e-05 | 156 | 238 | 8 | C2585653 | |
| Disease | Atrial Fibrillation | 4.96e-05 | 160 | 238 | 8 | C0004238 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 5.96e-05 | 10 | 238 | 3 | EFO_0022090 | |
| Disease | Bartter disease type 4B | 6.48e-05 | 2 | 238 | 2 | cv:C4310805 | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 6.48e-05 | 2 | 238 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 6.48e-05 | 2 | 238 | 2 | 613090 | |
| Disease | BARTTER SYNDROME, TYPE 4B | 6.48e-05 | 2 | 238 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 6.48e-05 | 2 | 238 | 2 | C4310805 | |
| Disease | Bartter disease type 4b (is_implicated_in) | 6.48e-05 | 2 | 238 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | Bartter disease (implicated_via_orthology) | 6.48e-05 | 2 | 238 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | response to cisplatin, platinum measurement | 6.85e-05 | 53 | 238 | 5 | EFO_0010154, GO_0072718 | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 7.26e-05 | 28 | 238 | 4 | DOID:0050866 (is_implicated_in) | |
| Disease | Large cell carcinoma of lung | 1.24e-04 | 32 | 238 | 4 | C0345958 | |
| Disease | myoglobinuria (implicated_via_orthology) | 1.93e-04 | 3 | 238 | 2 | DOID:0080108 (implicated_via_orthology) | |
| Disease | serum clozapine-to-N-desmethylclozapine ratio measurement | 1.93e-04 | 3 | 238 | 2 | EFO_0600042 | |
| Disease | cholic acid glucuronide measurement | 1.93e-04 | 3 | 238 | 2 | EFO_0800574 | |
| Disease | X-21258 measurement | 1.93e-04 | 3 | 238 | 2 | EFO_0800802 | |
| Disease | obsolete_red blood cell distribution width | ABL1 ATR CDK12 EZH2 BIRC6 FZR1 MAST4 C1orf105 NUFIP2 TBC1D14 UGT2B15 HERC1 GRIN3B TTC28 LARP1 MON1A RFC1 ECT2 TFRC INTS10 RESF1 LPIN2 ELAVL2 BORA | 2.51e-04 | 1347 | 238 | 24 | EFO_0005192 |
| Disease | retinal vein occlusion (is_marker_for) | 3.85e-04 | 4 | 238 | 2 | DOID:1727 (is_marker_for) | |
| Disease | X-25937 measurement | 3.85e-04 | 4 | 238 | 2 | EFO_0800937 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 3.85e-04 | 4 | 238 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | inflammatory bowel disease (is_implicated_in) | 4.56e-04 | 19 | 238 | 3 | DOID:0050589 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | CYP2C19 ATR CDK12 SLC26A4 SERPINF1 EZH2 UGT2B15 UGT2B17 KMT2A MGA AGR2 LMTK2 PPL NCOA7 | 5.23e-04 | 616 | 238 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | CYP2C19 ATR CDK12 SLC26A4 SERPINF1 EZH2 UGT2B15 UGT2B17 KMT2A MGA AGR2 LMTK2 PPL NCOA7 | 5.23e-04 | 616 | 238 | 14 | C0376358 |
| Disease | docosahexaenoic acid measurement | 5.93e-04 | 127 | 238 | 6 | EFO_0007761 | |
| Disease | Autism Spectrum Disorders | 6.35e-04 | 85 | 238 | 5 | C1510586 | |
| Disease | Weaver syndrome | 6.38e-04 | 5 | 238 | 2 | C0265210 | |
| Disease | quality of life during menstruation measurement, eating behaviour | 6.38e-04 | 5 | 238 | 2 | EFO_0007829, EFO_0009366 | |
| Disease | Iron Metabolism Disorders | 6.38e-04 | 5 | 238 | 2 | C0012715 | |
| Disease | internal carotid intimal medial thickness | 6.38e-04 | 5 | 238 | 2 | EFO_0005053 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 7.10e-04 | 50 | 238 | 4 | EFO_0010732 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 7.44e-04 | 88 | 238 | 5 | EFO_0803332 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 8.05e-04 | 301 | 238 | 9 | DOID:684 (is_marker_for) | |
| Disease | kidney failure (is_marker_for) | 9.51e-04 | 6 | 238 | 2 | DOID:1074 (is_marker_for) | |
| Disease | endometriosis (is_implicated_in) | 9.51e-04 | 6 | 238 | 2 | DOID:289 (is_implicated_in) | |
| Disease | Premature Ovarian Failure 1 | 9.51e-04 | 6 | 238 | 2 | C4552079 | |
| Disease | Gonadotropin-Resistant Ovary Syndrome | 9.51e-04 | 6 | 238 | 2 | C0086367 | |
| Disease | Hypergonadotropic Ovarian Failure, X-Linked | 9.51e-04 | 6 | 238 | 2 | C3494522 | |
| Disease | Bartter syndrome | 9.51e-04 | 6 | 238 | 2 | cv:C0004775 | |
| Disease | acute lymphoblastic leukemia (implicated_via_orthology) | 9.51e-04 | 6 | 238 | 2 | DOID:9952 (implicated_via_orthology) | |
| Disease | alcohol consumption measurement | CDK12 IFT172 ADGRV1 BIRC6 NRXN3 MAST4 NRXN1 ZNF608 NUFIP2 MGA PCLO GLRA3 RFC1 FAM135B ZZZ3 STK33 PTCD2 ELAVL2 CTNND2 HAS3 SORL1 | 1.19e-03 | 1242 | 238 | 21 | EFO_0007878 |
| Disease | amino acid measurement | GABRG3 SETX TGM5 AXIN2 PER3 MTUS2 VWF ARHGEF28 MCPH1 LARP1 RAD51AP2 TENM4 ELAVL2 NRG3 | 1.31e-03 | 678 | 238 | 14 | EFO_0005134 |
| Disease | Solid Neoplasm | 1.32e-03 | 7 | 238 | 2 | C0280100 | |
| Disease | X-24574 measurement | 1.32e-03 | 7 | 238 | 2 | EFO_0800897 | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 1.32e-03 | 7 | 238 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | pulse pressure measurement, anxiety | 1.32e-03 | 7 | 238 | 2 | EFO_0005230, EFO_0005763 | |
| Disease | cognitive function measurement | GABRG3 AFTPH NCAM2 BIRC6 NRXN3 MAST4 NRXN1 ZNF608 UGT2B15 BAIAP2 DOCK3 TTC28 WRN APBA1 FAM135B SLC9A2 TENM4 LRRC53 RAB11FIP5 ELAVL2 TMEM131 EXOC2 CTNND2 | 1.40e-03 | 1434 | 238 | 23 | EFO_0008354 |
| Disease | corpus callosum central volume measurement | 1.46e-03 | 28 | 238 | 3 | EFO_0010296 | |
| Disease | apolipoprotein A 1 measurement | FZR1 TRANK1 UGT2B15 KMT2A HERC1 MGA PHIP ARHGEF28 PUM2 SPG11 RFX4 LHCGR INTS10 LPIN2 PTCD2 SORL1 | 1.54e-03 | 848 | 238 | 16 | EFO_0004614 |
| Disease | prostate cancer (is_marker_for) | 1.72e-03 | 156 | 238 | 6 | DOID:10283 (is_marker_for) | |
| Disease | deoxycholic acid glucuronide measurement | 1.76e-03 | 8 | 238 | 2 | EFO_0800575 | |
| Disease | myelofibrosis (is_implicated_in) | 1.76e-03 | 8 | 238 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | diffuse large B-cell lymphoma (is_marker_for) | 1.76e-03 | 8 | 238 | 2 | DOID:0050745 (is_marker_for) | |
| Disease | D dimer measurement | 1.79e-03 | 30 | 238 | 3 | EFO_0004507 | |
| Disease | Colorectal Carcinoma | AXIN2 CDKL5 FAT1 SERPINB5 PHIP CNTN1 PARP8 WRN PREX2 TFRC ZZZ3 CTNND2 SPAG17 SORL1 | 1.81e-03 | 702 | 238 | 14 | C0009402 |
| Disease | C-X-C motif chemokine 10 measurement | 1.94e-03 | 109 | 238 | 5 | EFO_0008056 | |
| Disease | alcoholic liver cirrhosis (is_marker_for) | 2.25e-03 | 9 | 238 | 2 | DOID:14018 (is_marker_for) | |
| Disease | N-acylethanolamine-hydrolyzing acid amidase measurement | 2.25e-03 | 9 | 238 | 2 | EFO_0008240 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 2.25e-03 | 9 | 238 | 2 | EFO_0600040 | |
| Disease | neuroticism measurement, cognitive function measurement | PPP1R12B BIRC6 PTPRO BAIAP2 SHISA6 PCLO ZNF507 ZZZ3 TENM3 RAB11FIP5 ELAVL2 CTNND2 | 2.31e-03 | 566 | 238 | 12 | EFO_0007660, EFO_0008354 |
| Disease | reticulocyte measurement | ATR PLPPR3 BIRC6 FZR1 FAT1 C1orf105 VAV2 TNS3 VWF ARHGEF28 COPB1 LARP1 RFC1 TFRC LPIN2 NCOA7 TMEM131 PDZD2 | 2.35e-03 | 1053 | 238 | 18 | EFO_0010700 |
| Disease | androsterone sulfate measurement | 2.36e-03 | 33 | 238 | 3 | EFO_0021117 | |
| Disease | depressive symptom measurement | 2.56e-03 | 426 | 238 | 10 | EFO_0007006 | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 2.79e-03 | 10 | 238 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | quality of life during menstruation measurement, aggressive behavior | 2.79e-03 | 10 | 238 | 2 | EFO_0003015, EFO_0009366 | |
| Disease | Cardiovascular Diseases | 3.04e-03 | 36 | 238 | 3 | C0007222 | |
| Disease | X-11308 measurement | 3.40e-03 | 11 | 238 | 2 | EFO_0800693 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 3.40e-03 | 11 | 238 | 2 | EFO_0801531 | |
| Disease | Abnormality of refraction | GABRG3 CDK12 BIRC6 AXIN2 ZNF608 C6 SHISA6 DOCK3 RASGRF1 PCLO MON1A PTCD2 CTNND2 | 3.42e-03 | 673 | 238 | 13 | HP_0000539 |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.60e-03 | 447 | 238 | 10 | EFO_0000694, MONDO_0100096 | |
| Disease | heel bone mineral density, urate measurement | 3.70e-03 | 182 | 238 | 6 | EFO_0004531, EFO_0009270 | |
| Disease | thymol sulfate measurement | 4.05e-03 | 12 | 238 | 2 | EFO_0021170 | |
| Disease | triacylglycerol 58:12 measurement | 4.05e-03 | 12 | 238 | 2 | EFO_0010439 | |
| Disease | Charcot-Marie-Tooth Disease | 4.05e-03 | 12 | 238 | 2 | C0007959 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 4.05e-03 | 12 | 238 | 2 | EFO_0800291 | |
| Disease | X-11444 measurement | 4.77e-03 | 13 | 238 | 2 | EFO_0021237 | |
| Disease | complement component C6 measurement | 4.77e-03 | 13 | 238 | 2 | EFO_0020281 | |
| Disease | Sjogren's Syndrome | 4.77e-03 | 13 | 238 | 2 | C1527336 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 4.77e-03 | 13 | 238 | 2 | EFO_0800293 | |
| Disease | Sicca Syndrome | 4.77e-03 | 13 | 238 | 2 | C0086981 | |
| Disease | X-19141 measurement | 4.77e-03 | 13 | 238 | 2 | EFO_0800799 | |
| Disease | reticulocyte count | ATR PLPPR3 BIRC6 FZR1 FAT1 C1orf105 HERC1 TNS3 VWF ARHGEF28 COPB1 LARP1 RFC1 TFRC NCOA7 TMEM131 PDZD2 | 5.05e-03 | 1045 | 238 | 17 | EFO_0007986 |
| Disease | neuropsychological test | 5.42e-03 | 197 | 238 | 6 | EFO_0003926 | |
| Disease | C-X-C motif chemokine 11 measurement | 5.53e-03 | 14 | 238 | 2 | EFO_0008057 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 5.53e-03 | 14 | 238 | 2 | EFO_0800283 | |
| Disease | childhood trauma measurement, smoking behaviour measurement | 5.73e-03 | 45 | 238 | 3 | EFO_0005671, EFO_0007979 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | NCAM2 BIRC6 TMEM132B NRXN3 NRXN1 NUFIP2 BAIAP2 HERC1 TTC28 FAM135B TENM4 ELAVL2 NRG3 SORL1 | 5.81e-03 | 801 | 238 | 14 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Thrombus | 6.09e-03 | 46 | 238 | 3 | C0087086 | |
| Disease | Alcoholic Intoxication, Chronic | 6.29e-03 | 268 | 238 | 7 | C0001973 | |
| Disease | cancer biomarker measurement | 6.35e-03 | 15 | 238 | 2 | EFO_0005127 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 6.35e-03 | 15 | 238 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | Osteosarcoma | 6.47e-03 | 47 | 238 | 3 | C0029463 | |
| Disease | Primary Ciliary Dyskinesia | 6.47e-03 | 47 | 238 | 3 | C4551720 | |
| Disease | IGF-1 measurement | MARK1 UGT2B15 UGT2B17 BAIAP2 NSMAF DOCK3 SORBS2 E2F3 RESF1 NCOA7 | 6.58e-03 | 488 | 238 | 10 | EFO_0004627 |
| Disease | body weight | GABRG3 ATAD5 ADGRV1 SPATA31C1 AXIN2 ACSL3 NRXN3 MAST4 NRXN1 GLRA1 BAIAP2 MGA COPB1 RASGRF1 WDR70 MON1A LHCGR ELAVL2 PDZD2 | 6.94e-03 | 1261 | 238 | 19 | EFO_0004338 |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 7.22e-03 | 16 | 238 | 2 | C1839071 | |
| Disease | Schizoaffective disorder-bipolar type | 7.22e-03 | 16 | 238 | 2 | EFO_0009965 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 7.22e-03 | 16 | 238 | 2 | cv:C1839071 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSSKPYTEAASSKQL | 1031 | Q14146 | |
| SYTLARDTTVKPGAK | 16 | O95994 | |
| AKIYTQASKSPTSTI | 1201 | Q68DN1 | |
| DDTSTCKTITKYLSP | 31 | Q96QE3 | |
| PRKLYKHSSTSSRIA | 26 | Q9BSF8 | |
| LYSQKATPGSSRKTC | 151 | Q12834 | |
| RTSRSTKANYSKNSP | 81 | Q9Y6F8 | |
| RTSRSTKANYSKNSP | 81 | Q9Y6F7 | |
| SYKKSPGSTSRRQSV | 261 | Q9NYV4 | |
| SSVPNTSQSYAKVIK | 176 | Q15018 | |
| RVITDPSLSKTDSYK | 4011 | Q9NR09 | |
| TRPSYPKRSSKSSCS | 156 | Q5JRM2 | |
| SKGRKPLSTHSTEYN | 206 | Q6ULP2 | |
| LARAKSVPTKTYSNE | 286 | Q07002 | |
| QKYSSSLFKTSQLAP | 91 | Q96Q27 | |
| KRSFSLDIKSAYAPS | 391 | Q13202 | |
| PQISYASTSAKLSDK | 161 | Q14416 | |
| SSNESKDLTPSKGYI | 3126 | Q8WXG9 | |
| CYKTFLSPATSETKR | 281 | Q5VU97 | |
| ATDLLKRLYSTSASP | 426 | Q9Y2Z9 | |
| ILTTKQSSYFPTLKD | 306 | Q96DT5 | |
| SAQSTKKAYPLESAR | 636 | Q9Y2T1 | |
| QTKTIKVSYARPSSA | 106 | Q14576 | |
| ALKYSNKKTGSNPTS | 236 | Q63HQ0 | |
| LSKQYSSRDLPSHTK | 26 | Q9P013 | |
| PTKAYDSTVLKTRGN | 186 | Q8N865 | |
| VSPGQLTKKYSSCST | 111 | Q8N7R7 | |
| KQSPSRLAKSYSTSS | 301 | Q9UQB3 | |
| RTLPSSSCLVAYKKT | 546 | Q9Y2H0 | |
| TDTSPSGTKKTRQYL | 146 | Q69YU3 | |
| ATSLYSSDPSADLKK | 806 | Q5JR59 | |
| YPSLSSQNTCKRKDL | 331 | Q09MP3 | |
| FICTAKSKSPAYTLV | 1791 | P98160 | |
| SSSSKNLAVKVYTPV | 106 | Q9NS91 | |
| VSKQTVAYSPRSKLG | 161 | Q33E94 | |
| KKYDLESASAILPSS | 201 | Q9BXF6 | |
| SINYGDTPKSCTKSS | 426 | Q9H8V3 | |
| SGSRASLPKVSYVKA | 301 | O75311 | |
| KINPTSSLYKSLVSG | 116 | O75665 | |
| RYFNSKVPITRTKST | 436 | Q9Y2R2 | |
| SSDLYKRSSSSLAPI | 591 | Q8TB72 | |
| TSDLMSPSKRSSQKY | 226 | Q9NVR2 | |
| SPSKRSSQKYIIEGL | 231 | Q9NVR2 | |
| KVSTPSDYTLSFLKR | 596 | O00255 | |
| SYSCSSPKISLGKTR | 556 | Q8N1W1 | |
| FISYAIPDVSKRTKS | 851 | Q4KMQ2 | |
| LKYSSSGLKTQRNTS | 551 | P56975 | |
| YTLQSSRDPLSLKKF | 1491 | Q14517 | |
| SPSSYKQDFTNSKLL | 451 | Q92585 | |
| LKDSSQTSRFYPVVK | 791 | Q6PKG0 | |
| STPTYKKSLRLSSDQ | 586 | Q9BQK8 | |
| DSTEATAKPKRSFYA | 81 | Q5TC84 | |
| QSPESKKLVSLSYTV | 266 | Q8NGE5 | |
| KSYSSAPKSSKTELF | 431 | Q8N3A8 | |
| LTAPKKSATQFTGRY | 241 | Q8NCW5 | |
| YKGRSTINPSKASTN | 6 | Q13823 | |
| TSSYSLKKLPSRETF | 251 | P22888 | |
| FEEKYRLSPTLSSTK | 326 | Q8NEM0 | |
| SSSTYSKRCRKPSKS | 126 | Q8NCT3 | |
| VLKKQSTISPSTSYS | 871 | Q8IWI9 | |
| TFSGRTKSSYKSILP | 906 | Q8IWI9 | |
| KLVAYKRKPSSSTSG | 1461 | Q8IWI9 | |
| QGCPRSKLSKSTYEE | 71 | Q9NYK6 | |
| DLSGLSTKTKKAYSP | 621 | A6NM62 | |
| LQTKASPGSSSYLKL | 3191 | Q2LD37 | |
| SSLPRTLSKESKLYG | 3901 | Q2LD37 | |
| TYKPNQSTDAKTATR | 1016 | Q9ULE4 | |
| SGLTSKVRPAKQLTY | 461 | Q6ZUT3 | |
| KSTSSERYKGQAPDL | 3051 | Q15751 | |
| ERSTKQSLFTKYPLE | 2436 | Q5CZC0 | |
| ATPNTYKRKNTETAL | 301 | Q15910 | |
| NKSSPRFSKSLTETY | 2566 | Q9Y6V0 | |
| VDKFREKILSSPYSS | 691 | P56645 | |
| AVYLTPESKSSFKQA | 866 | Q96KP1 | |
| GKYSPTVQTRSISNK | 11 | O60437 | |
| KELSGSSSAPKLEYT | 1076 | O15018 | |
| ASAKVLSLKYSTPRE | 1626 | O15018 | |
| YATQSALSSSRPTKK | 521 | P53618 | |
| PKSASYSLESTDVKS | 696 | Q9H706 | |
| SLRPDLKTKSYGNIS | 416 | Q8NCW6 | |
| SYRSLDITPGKNSRK | 511 | Q86SU0 | |
| RPSSKKTYSLRSQAS | 1701 | Q96Q89 | |
| DPVTFKTKSSYLSLA | 871 | Q9Y4C0 | |
| KIAFKLLELTSSYSP | 476 | P38432 | |
| SSLEKYSPDSAAKVQ | 936 | O60449 | |
| LLSSKPSLQTSKYFS | 1436 | Q8IWU2 | |
| KKGYSSRRVQSPSSK | 101 | Q7L4E1 | |
| KKTASNSKLRTYLPD | 281 | Q13630 | |
| ARTAKDPNTYKVLSL | 66 | P22413 | |
| LQSKTIKVSYARPSS | 86 | Q15717 | |
| NIIADPVTFKTKSSY | 901 | Q9ULB1 | |
| PVTFKTKSSYVALAT | 906 | Q9ULB1 | |
| RLANTKTNKSSTIYG | 136 | Q9UG01 | |
| KQDSNPLYKSAITTT | 771 | P26010 | |
| KSQSAKSLSFYISPS | 411 | Q16827 | |
| PSSIKIINYKNISSS | 611 | Q9UMZ3 | |
| IKLYTSKSELPTDNS | 741 | O43422 | |
| LAPSKAQDSKAYTSI | 396 | P09923 | |
| APDTKETIFSISKAY | 411 | O60313 | |
| KNKDVYPSCSSTTAS | 696 | Q6PIJ6 | |
| EISYKSLPRTSTQSK | 636 | Q5VYJ5 | |
| LYKSKSSGLFTSPEI | 546 | Q86VX9 | |
| TPEKKGLFTYSLSTK | 121 | Q9UM11 | |
| PHLNTRYKSSQKSTD | 1456 | Q13535 | |
| VASTCRKTNKLSPYD | 61 | P07199 | |
| CQSRDSYKSKAPSLL | 486 | Q711Q0 | |
| KSTYSSSPLLKVLDE | 511 | Q711Q0 | |
| SKSLTNLSKIYGPVF | 51 | P33261 | |
| KSPSEKTRYDTSLGL | 171 | O00716 | |
| SLAKSYASTPELRKT | 1606 | Q5JSL3 | |
| RTILTTSNSFPYVKK | 1886 | Q5JSL3 | |
| IRKSSAKYSAPSASH | 361 | Q8IZD9 | |
| KTKREFLKASSSSPY | 216 | Q9UBN1 | |
| GICKTVKSSRTSNPY | 216 | P13671 | |
| TLNYYSSCRKPTTTK | 336 | Q99928 | |
| GLARAKSIPTKTYSN | 306 | Q00536 | |
| KYQSTSANSLKRLPS | 266 | P57773 | |
| PVSSSALKYLLTQKG | 161 | Q6ZPD8 | |
| SSPIQASAKKYSLGS | 251 | Q6PGQ7 | |
| LTPKAGLKQSTYTSS | 151 | Q8N1D5 | |
| KGNYSCFVSSPSITK | 206 | Q12860 | |
| KESDTSYVSLKAPLT | 31 | P02741 | |
| TAPESLAYNKFSIKS | 406 | P00519 | |
| STELSYILPSEAAKK | 1271 | Q9BZC7 | |
| KESRKSLASFPTYVE | 431 | Q02410 | |
| QTKTIKVSYARPSSA | 106 | Q12926 | |
| LPRKTSLSSDSNKTF | 1631 | Q99698 | |
| SSGSRASLPKVSYVK | 301 | P23416 | |
| ERKKSSTIPSNNVYS | 481 | Q9P0L2 | |
| TSIKTGPARRNSYKS | 1231 | O15021 | |
| SSTIKSTPSGKRYKF | 306 | P33241 | |
| ITPKFKSLSQTSSYN | 576 | Q92636 | |
| VELSSTRKLSKYSNP | 121 | Q8NC69 | |
| SSSALYPVGRVSKEK | 901 | Q03164 | |
| TKYTARSKCLTETPT | 331 | O00219 | |
| DKDTTKPISFYLSSL | 76 | Q8NFI3 | |
| PKTKLGSRTTYQCSR | 261 | Q8NDH2 | |
| SKSLTNLSKVYGPVF | 51 | P11712 | |
| LTYIDVKSSNKNPSR | 551 | Q49AJ0 | |
| PRSTYGSTTNDKLKE | 361 | Q3B820 | |
| CNLTPDTLTSDTYKK | 341 | P17655 | |
| AKRKPYHVESSTLSN | 311 | O76039 | |
| FYKPITKDQLSSRSE | 66 | Q969H9 | |
| LKRCNSGSDSPYSKI | 226 | Q8N7B9 | |
| DFCKKTTVPTNTYTL | 401 | Q9C0B2 | |
| PLESFNYVLSKSTKA | 861 | Q2NKX8 | |
| FLVAYTKKAPQLTSS | 431 | P02771 | |
| LIKTPTKSFAVYAAT | 101 | Q9H8W4 | |
| SSPLRLGSYKAQKTS | 356 | O14830 | |
| YKLNSPESFKICTTL | 211 | Q8WV60 | |
| NNSPESKKLLSLSYT | 266 | Q9H207 | |
| ASIIYLKPKSQSSLG | 256 | Q5JRS4 | |
| SVHKSSTSYRPQKLA | 591 | Q4G0U5 | |
| SPLTSNLSEFISRYK | 781 | O60391 | |
| ESSYQLSRHKKSPSS | 581 | Q9HCH5 | |
| SSKPAIGSKAVNYSS | 21 | Q96A25 | |
| PYSAKTLSNKKSSAS | 41 | A8K8P3 | |
| TSKSNLSYNTKFAIP | 26 | Q8NEY4 | |
| TSFLDLYRNPKSLTT | 1876 | Q92673 | |
| PAYGTLTKNLSEKRS | 1136 | Q8TEU7 | |
| TATKYPAKSGALSRT | 496 | Q9BYT3 | |
| YFPSRVSIKESSVAK | 141 | Q9Y3A3 | |
| KSHILDSSIYSNRPK | 121 | Q14DG7 | |
| SSGPKRKRVKFTSYT | 1016 | Q14DG7 | |
| SLKTLYRKSASLDSP | 816 | Q8NI08 | |
| KTAQVSDERKSYSPR | 271 | P35251 | |
| SSSKFSRILTPKEYL | 1436 | Q9HCM1 | |
| SGSRASLPKVSYVKA | 296 | P23415 | |
| KEISSYTPKDCTSRN | 716 | Q7Z333 | |
| TNPSKYSSLKRLTDK | 306 | Q6ZSJ9 | |
| STEFISSTKRPYAKE | 101 | P36952 | |
| SYKSPVTTLDKSTGI | 176 | Q6UW49 | |
| SKGKDLYRSNISPLT | 261 | O75626 | |
| SYKPCDKISSGSNIS | 1111 | Q14191 | |
| NSYTTPSKGSQKRAI | 111 | Q14181 | |
| KYRAQLLEPSKSASS | 36 | P55039 | |
| SKPLTYSLKGSTQQS | 776 | P0DKV0 | |
| SSSQRPIKLKEASYS | 91 | Q5T5J6 | |
| GSLYAKVRKKSSSDP | 351 | Q68CZ2 | |
| ESLSPKKYSSSLRFK | 36 | Q86SQ0 | |
| KALYFITPTSKSVDC | 76 | O00186 | |
| PFSKATLDTSKLYVS | 791 | Q13972 | |
| TSNFKVSASPLLYTL | 491 | P02786 | |
| AKTQTYRPLSKSHSD | 141 | O94875 | |
| SYSQSKSRSKSLPRR | 146 | Q8WXF0 | |
| TTYFLPLANTLKSKA | 586 | Q5JTH9 | |
| EATVLTSSNYDKRPK | 2176 | Q6Q759 | |
| TTSQSTKSRYVPNGK | 1141 | Q8TER0 | |
| PAVYQLRDSKSSDKS | 6 | P01848 | |
| YSKVTNSLSLFIPKS | 996 | Q8NFU7 | |
| SKLSDSYSNTLPVRK | 331 | Q9UQB8 | |
| RYPHTSATFLTSSKK | 36 | O95561 | |
| YSSPQTLADQSSKIK | 351 | O95573 | |
| SLVYSDKKSAAATSP | 726 | Q96RK0 | |
| TTPGTNIKLYNKITS | 191 | Q92989 | |
| KRLTSECVSSNPYSK | 101 | Q8IYA6 | |
| TFSNSTLNKTSYPEK | 356 | Q86WS4 | |
| KTNRYSSKLLATSKP | 311 | P51800 | |
| SSKLLATSKPVYSAL | 316 | P51800 | |
| SSKLLATSKPVYSAL | 316 | P51801 | |
| TSKYLELNSLPSKET | 1851 | Q96JI7 | |
| KSSTFPRTGYDSVKL | 126 | Q9P2M4 | |
| DSVKLYSPTSKALTR | 136 | Q9P2M4 | |
| YFNSTLTDSSKLLKP | 266 | Q7Z2D5 | |
| ISSRYKADLSPENAK | 5101 | Q63HN8 | |
| SGETPLSAYKVKSRT | 431 | Q8IXZ2 | |
| SLVSPLQKIYSSVKS | 141 | Q6PDB4 | |
| KLLSDTSVIQFYPSK | 216 | Q7Z3J2 | |
| QLSPKTFASKTYGLC | 2071 | P04275 | |
| DNSSAKIVPKISYAS | 346 | Q7Z417 | |
| KSSFVAPLEKSYGTR | 151 | P36955 | |
| LPAKNTTNLKTYSTG | 441 | O15394 | |
| NSKAYTPSKRSRIYS | 1391 | Q8WWQ0 | |
| YTKLPSSLQSTGKCL | 61 | Q9BZJ4 | |
| LGSIPSTDIYKSTKN | 521 | O43511 | |
| LSSYLSTEKDASPKT | 491 | Q9BW04 | |
| STSTSRYLSLPKNTK | 661 | Q9UBY0 | |
| SENPRALKNYTKSTL | 241 | Q96MW7 | |
| KRKTYNSHLAESTSP | 291 | Q96AG3 | |
| YFNSVISDTTKLLKP | 221 | Q6T4P5 | |
| PAVYQLRDSKSSDKS | 141 | P0DTU3 | |
| KKVIPTTCTYSRDGN | 331 | Q9NW82 | |
| SQSKKYSTQIECLSP | 31 | Q92670 | |
| KPGSSTDSLYKLSLQ | 1571 | Q92545 | |
| EGKAPQKSYSSSETL | 31 | Q6N022 | |
| PTQKSYSSSETLKAF | 36 | Q9P273 | |
| TTKSYPSKLARNESR | 471 | O43516 | |
| LSSITYSPKLERKTS | 1051 | Q70Z35 | |
| DTAFITLSPKEAKTY | 561 | O43548 | |
| SSSYDKPITFLSLKL | 646 | Q86X10 | |
| FCKKSGQSYSPSRVL | 461 | Q96S55 | |
| EKLSPTSNTSYSLEK | 881 | Q8TCN5 | |
| KQCSKALPDSSSYIR | 256 | Q8TA94 | |
| KSHLRKNPPTYSSST | 1466 | Q96AY4 | |
| TSKDANKSLPSAALY | 111 | Q9ULD9 | |
| LSTSRKRIESPFAKY | 31 | Q96NB3 | |
| FLKSYSTSSKKARPV | 221 | Q96S44 | |
| NYSLPITVKKTSSQL | 346 | Q9Y5Q8 | |
| YSPTKELNRKLSSDE | 431 | O43895 | |
| SPQKQKSASALTYTA | 1111 | Q70CQ4 | |
| ASKSSAIKLEVYPTS | 66 | P54855 | |
| TTLKYPYKSRERSAS | 761 | P52735 | |
| PNEYRKGSTVKSSLI | 261 | Q8N883 | |
| TKTLPISKLSYSASQ | 1851 | O15050 | |
| TPATALAVRYASKKS | 21 | Q9P0M9 | |
| PKSSYADKAPSRSLN | 541 | Q8IY18 | |
| TNLATGIPSSKVKYS | 6 | Q96A57 | |
| GIPSSKVKYSRLSST | 11 | Q96A57 | |
| RTPNLYIYSKKSSTS | 716 | Q8IYH5 | |
| SKLKRSYSSPDITQA | 711 | P40818 | |
| PLLSTSKSTRNYAKA | 551 | Q9H2Y7 | |
| ASKSSAIKLEVYPTS | 66 | O75795 | |
| HIYSQKLSRPSSAKA | 981 | Q6EMB2 | |
| LSNLYKRPSFEESKT | 556 | A8MT70 | |
| KQSGTLLKPTDSYSS | 61 | Q7Z402 | |
| SKYTAFVPVDVSKSR | 896 | Q5TIE3 | |
| LKPLTRSKRDSTYSQ | 731 | Q5R3F8 | |
| PTGYVEKITCSSSKR | 76 | O76095 | |
| PLSHGSTTSYKKSLR | 626 | Q92539 | |
| KPCEASSKTVVYRTS | 151 | Q13508 | |
| SSLLLDDYSSKLSPK | 101 | P52179 | |
| KAPSSQTFSLARPKY | 711 | Q86TC9 | |
| KSYISSLAPRKLNST | 491 | O60237 | |
| STYLKRTPHKSQADT | 551 | O60237 |